Data / Research funding / Stem Cell and Progenitor Cell Research
Stem Cell and Progenitor Cell Research: 3,819 NIH awards ($5.7B) to 378 organizations
3,819 NIH awards ($5.7B) in the NIH spending category Stem Cell and Progenitor Cell Research, to 378 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 3,819 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Washington National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $66,616,318 | June 10, 1997 | April 30, 2027 | OSTENDORF, MARI | reporter.nih.gov |
| National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | NIH | National Institute on Aging | 2021 to 2025 | $65,403,220 | July 15, 2002 | May 31, 2027 | FOROUD, TATIANA M. | reporter.nih.gov |
| Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $36,418,175 | September 15, 2017 | August 31, 2031 | HAMADANI, MEHDI HUSSAIN | reporter.nih.gov |
| A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research | NIH | National Cancer Institute | 2021 to 2025 | $30,268,190 | March 1, 1998 | February 29, 2028 | SHAW, BRONWEN | reporter.nih.gov |
| Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial | NIH | National Institute on Aging | 2021 to 2025 | $28,784,116 | August 15, 2019 | April 30, 2027 | BRINTON, ROBERTA EILEEN | reporter.nih.gov |
| RADX BLUEPRINT MEDTECH TRANSLATOR COHORT 2 - COMMERCIALIZATION CENTER - HEAL | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $27,543,152 | June 2, 2025 | June 1, 2026 | reporter.nih.gov | |
| EO14042 DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $25,277,032 | November 1, 2021 | October 31, 2026 | MENEZES, SUPRIYA | reporter.nih.gov |
| The Origins of Alzheimer Disease in African Americans | NIH | National Institute on Aging | 2022 to 2025 | $20,889,453 | September 15, 2022 | June 30, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| SCREENING OF INVESTIGATIONAL THERAPEUTICS TO TREAT, MODIFY OR PREVENT EPILEPSY FOR THE NINDS EPILEPSY THERAPY SCREENING PROGRAM (ETSP) | NIH | National Institute on Drug Abuse | 2022 to 2025 | $20,858,598 | March 23, 2022 | December 31, 2025 | WILCOX, KAREN | reporter.nih.gov |
| Replication Study of Off-Target Assays for Guide RNAs in CRISPR-Based Therapeutics | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $17,077,732 | December 1, 2024 | April 30, 2025 | SAHA, KRISHANU | reporter.nih.gov |
| Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias | NIH | National Institute on Aging | 2021 to 2025 | $15,514,157 | September 30, 2021 | May 31, 2027 | ELLERBY, LISA M | reporter.nih.gov |
| Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies | NIH | National Institute on Aging | 2022 to 2025 | $14,689,794 | September 15, 2019 | December 31, 2026 | PERLS, THOMAS T | reporter.nih.gov |
| Personalized Modeling of CAR-T Cell Immunotherapy Using iPSC-Derived Effectors and Patient- Derived Tumor Organoids | NIH | National Cancer Institute | 2023 to 2025 | $12,675,268 | March 1, 1997 | August 31, 2026 | LIBUTTI, STEVEN K. | reporter.nih.gov |
| Advancing brain health research through male germline editing in marmosets | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,061,296 | August 1, 2021 | May 31, 2027 | HERMANN, BRIAN PETER | reporter.nih.gov |
| Center for Live Cell Genomics | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,992,289 | September 15, 2021 | June 30, 2027 | HAUSSLER, DAVID H | reporter.nih.gov |
| Supplement to TR01 Human cortical development and neural plasticity altered by trisomy 21 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $11,380,369 | September 10, 2021 | August 31, 2027 | BHATTACHARYYA, ANITA | reporter.nih.gov |
| Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder | NIH | National Institute on Drug Abuse | 2021 to 2025 | $11,197,081 | September 30, 2021 | July 31, 2027 | RANA, TARIQ M | reporter.nih.gov |
| Site-Directed RNA Editing of Nav1.7 as a Novel Analgesic | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,194,636 | September 23, 2021 | August 31, 2027 | ROSENTHAL, JOSHUA J.C. | reporter.nih.gov |
| Scientific Management and Support to the National Institute of Mental Health (NIMH) Repository and Genomics Resource (NRGR) | NIH | National Institute on Drug Abuse | 2025 | $10,685,838 | August 11, 2025 | August 10, 2026 | reporter.nih.gov | |
| Determining the mechanism of pks+ E.coli-associated carcinogenesis in early onset colorectal cancer. | NIH | National Cancer Institute | 2022 to 2025 | $9,558,240 | September 20, 2022 | August 31, 2027 | O'REILLY, EILEEN MARY | reporter.nih.gov |
| Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,418,230 | September 1, 2021 | August 31, 2026 | GOATE, ALISON M | reporter.nih.gov |
| Identification of TDP-43 Modifiers Through Single-Cell Transcriptional and Epigenomic Dissection of ALS and FTLD-MND | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,106,321 | September 29, 2021 | August 31, 2026 | DONNELLY, CHRISTOPHER JAMES | reporter.nih.gov |
| High-Throughput Functional Annotation of Gene Regulatory Elements and Variants Critical to Complex Cellular Phenotypes | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,874,835 | September 1, 2021 | May 31, 2027 | GERSBACH, CHARLES A. | reporter.nih.gov |
| Multiscale functional characterization of genomic variation in human developmental disorders | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,736,987 | September 1, 2021 | May 31, 2027 | HON, GARY CHUNG | reporter.nih.gov |
| Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions | NIH | National Institute on Aging | 2021 to 2025 | $8,654,669 | July 1, 2021 | June 30, 2027 | TEMPLE, SALLY | reporter.nih.gov |
| Alzheimer variants: Propagation of shared functional changes across cellular networks | NIH | National Institute on Aging | 2021 to 2025 | $8,542,236 | July 15, 2021 | June 30, 2027 | DE JAGER, PHILIP L | reporter.nih.gov |
| Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $8,479,606 | May 1, 2021 | April 30, 2027 | EFRON, PHILIP A | reporter.nih.gov |
| Massively parallel characterization of variants and elements impacting transcriptional regulation in dynamic cellular systems | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,077,896 | September 1, 2021 | May 31, 2027 | SHENDURE, JAY ASHOK | reporter.nih.gov |
| Beyond GWAS: High Throughput Functional Genomics & Epigenome Editing to Elucidate the Effects of Genetic Associations for Schizophrenia | NIH | National Institute of Mental Health | 2021 to 2025 | $8,050,699 | April 1, 2021 | January 31, 2027 | CRAWFORD, GREGORY E | reporter.nih.gov |
| Higher Order Chromatin and Genetic Risk for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $7,828,464 | September 1, 2015 | May 31, 2027 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Restoring Vision with High-Fidelity Nonsense Codon Correction | NIH | National Eye Institute | 2021 to 2025 | $7,812,597 | February 1, 2021 | November 30, 2026 | PATTNAIK, BIKASH RANJAN | reporter.nih.gov |
| Reexamining the Role of Dendrites in Neuronal Function | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $7,740,604 | August 1, 2023 | July 31, 2028 | YUSTE, RAFAEL | reporter.nih.gov |
| JAX MorPhiC Data Production Center | NIH | National Human Genome Research Institute | 2022 to 2025 | $7,698,185 | August 4, 2022 | May 31, 2027 | ROBSON, PAUL | reporter.nih.gov |
| Early Phase Clinical Cancer Prevention Consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,613,555 | July 7, 2020 | July 31, 2031 | SCHUETZE, SCOTT MICHAEL | reporter.nih.gov |
| Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates | NIH | National Institute on Drug Abuse | 2023 to 2025 | $7,434,979 | June 1, 2023 | February 29, 2028 | RANA, TARIQ M | reporter.nih.gov |
| Application of Progenitor Niche Signals to Ex Vivo Nephrogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,389,413 | September 15, 2021 | June 30, 2027 | OXBURGH, LEIF | reporter.nih.gov |
| Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders | NIH | National Institute on Aging | 2021 to 2025 | $7,375,647 | July 1, 2021 | December 31, 2026 | REITZ, ALLEN BERNARD | reporter.nih.gov |
| Center for scalable knockout and multimodal phenotyping in genetically diverse human genomes | NIH | National Human Genome Research Institute | 2022 to 2025 | $7,316,442 | August 15, 2022 | May 31, 2027 | HUANGFU, DANWEI | reporter.nih.gov |
| TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,251,380 | September 1, 2021 | May 31, 2027 | DAVIES, STELLA MARGARET | reporter.nih.gov |
| Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging | NIH | National Institute on Aging | 2022 to 2025 | $7,239,829 | August 15, 2022 | June 30, 2027 | CRUCHAGA, CARLOS | reporter.nih.gov |
| Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure | NIH | National Institute on Drug Abuse | 2023 to 2025 | $7,084,951 | May 15, 2023 | March 31, 2028 | NDHLOVU, LISHOMWA C | reporter.nih.gov |
| Genomic control of gene regulatory networks governing early human lineage decisions | NIH | National Human Genome Research Institute | 2021 to 2025 | $7,036,239 | August 19, 2021 | May 31, 2026 | HUANGFU, DANWEI | reporter.nih.gov |
| Overcoming Barriers to retinal ganglion cell replacement in experimental glaucoma | NIH | National Eye Institute | 2021 to 2025 | $7,031,142 | September 30, 2021 | July 31, 2027 | MEYER, JASON STEPHEN | reporter.nih.gov |
| Primary Open Angle African-American Glaucoma Genetics Study Renewal | NIH | National Eye Institute | 2021 to 2025 | $6,924,827 | April 1, 2014 | March 31, 2026 | O'BRIEN, JOAN M | reporter.nih.gov |
| Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,908,458 | July 15, 2021 | June 30, 2027 | VANCE, JEFFERY MARVIN | reporter.nih.gov |
| The NINDS Human Cell and Data Repository (U24 renewal) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,898,547 | September 30, 2015 | July 31, 2030 | KNOWLES, JAMES A | reporter.nih.gov |
| Precision Editing of Granulin Mutations that Cause Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $6,580,415 | August 15, 2025 | July 31, 2029 | SONTHEIMER, ERIK J. | reporter.nih.gov |
| Spatial multiomic mapping of gene function with CRISPRoff | NIH | National Human Genome Research Institute | 2022 to 2025 | $6,562,020 | September 1, 2022 | June 30, 2027 | GILBERT, LUKE | reporter.nih.gov |
| Molecular and cellular characterization of essential human genes. | NIH | National Human Genome Research Institute | 2022 to 2025 | $6,526,413 | September 22, 2022 | June 30, 2027 | ADLI, MAZHAR | reporter.nih.gov |
| The effects of Alzheimer's disease risk genes on metabolism and signaling across cell types | NIH | National Institute on Aging | 2022 to 2025 | $6,477,664 | September 19, 2022 | August 31, 2027 | FRAENKEL, ERNEST | reporter.nih.gov |
| The impact of genomic variation on environment-induced changes in pancreatic beta cell states | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,348,795 | September 7, 2021 | May 31, 2027 | CARTER, HANNAH KATHRYN | reporter.nih.gov |
| Molecular Mechanisms of Pathogenesis in Huntington’s disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,238,150 | May 1, 2020 | April 30, 2028 | THOMPSON, LESLIE MICHELS | reporter.nih.gov |
| Design of Precision Small Molecules Targeting RNA Repeating Transcripts to Manipulate and Study Disease Biology | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,233,749 | May 1, 2020 | April 30, 2028 | DISNEY, MATTHEW D | reporter.nih.gov |
| Elucidate the roles of Alzheimer's disease risk genes and variants in gene expression and AD-related phenotypes | NIH | National Institute on Aging | 2022 to 2025 | $6,109,739 | September 15, 2022 | August 31, 2027 | SHEN, YIN | reporter.nih.gov |
| Leveraging genetic variation to dissect gene regulatory networks of reprogramming to pluripotency | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,016,057 | September 1, 2021 | May 31, 2027 | LUO, CHONGYUAN | reporter.nih.gov |
| Defining causal roles of genomic variants on gene regulatory networks with spatiotemporally-resolved single-cell multiomics | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,001,599 | September 1, 2021 | May 31, 2026 | WU, HAO | reporter.nih.gov |
| Dissecting the role of sex-linked genes and APOE e4 risk in AD | NIH | National Institute on Aging | 2021 to 2025 | $5,928,484 | September 30, 2021 | July 31, 2027 | YOUNG, JESSICA ELAINE | reporter.nih.gov |
| Chaperome networks in Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2025 | $5,927,093 | February 15, 2021 | January 31, 2027 | CHIOSIS, GABRIELA | reporter.nih.gov |
| Multimodal histologic atlas of human bone marrow | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,888,084 | August 1, 2022 | June 30, 2026 | BENDALL, SEAN CURTIS | reporter.nih.gov |
| Accelerating photoreceptor replacement therapy with in-vivo cellular imaging of retinal function | NIH | National Eye Institute | 2021 to 2025 | $5,733,511 | September 30, 2021 | January 31, 2027 | MCGREGOR, JULIETTE ELIZABETH | reporter.nih.gov |
| Environmental Biosensors in the Oligodendrocyte Lineage | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,732,603 | May 15, 2019 | April 30, 2027 | CASACCIA, PATRIZIA | reporter.nih.gov |
| NPTX2: Preserving memory circuits in normative aging and Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $5,697,103 | May 1, 2021 | April 30, 2027 | BARNES, CAROL A. | reporter.nih.gov |
| Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,598,826 | May 1, 2021 | April 30, 2029 | KRAINC, DIMITRI | reporter.nih.gov |
| The role of stem cells and the microenvironment in gastrointestinal cancers | NIH | National Cancer Institute | 2021 to 2025 | $5,569,272 | January 7, 2016 | August 31, 2030 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| Molecular Biology Across Scales Training Program | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $5,468,885 | July 1, 2023 | June 30, 2028 | BILDER, DAVID | reporter.nih.gov |
| Single-cell epigenomic and trancriptional dissection of sex-specific differences in Alzheimer’s Disease | NIH | National Institute on Aging | 2021 to 2025 | $5,445,522 | September 30, 2021 | May 31, 2027 | KELLIS, MANOLIS | reporter.nih.gov |
| New mechanisms and technologies for understanding post-transcriptional gene regulation in neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,391,456 | June 1, 2019 | May 31, 2027 | JAFFREY, SAMIE R | reporter.nih.gov |
| Mechanisms of neurodegenerative diseases: intersections with ubiquitin pathways | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,356,529 | May 1, 2021 | April 30, 2029 | PAULSON, HENRY L | reporter.nih.gov |
| Assay and Data Generation Center (ADGC) for the Model of iPSC-derived Neurons for NPD (MiNND) | NIH | National Institute of Mental Health | 2023 to 2025 | $5,271,743 | May 17, 2023 | April 30, 2028 | PANG, ZHIPING P. | reporter.nih.gov |
| Cell plasticity in the origin of gastric carcinogenesis | NIH | National Cancer Institute | 2022 to 2025 | $5,262,457 | September 1, 2025 | August 31, 2027 | CHOI, EUNYOUNG | reporter.nih.gov |
| Continuous Neurogenesis in the Mammalian Hippocampus | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,244,633 | May 1, 2020 | April 30, 2028 | SONG, HONGJUN | reporter.nih.gov |
| Novel therapeutic development for small cell lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,214,420 | August 10, 2021 | July 31, 2028 | RUDIN, CHARLES M. | reporter.nih.gov |
| The TGFÃÂÃÂÃÂò Signaling Pathway in Development and Cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,182,391 | September 1, 2020 | August 31, 2027 | MASSAGUE, JOAN | reporter.nih.gov |
| Cellular Decision Making | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,164,037 | June 1, 2016 | May 31, 2026 | WEINER, ORION D | reporter.nih.gov |
| Fecal Microbiota Transplantation and Fiber for the Treatment of Graft-versus-host Disease After Hematopoietic Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,128,451 | September 1, 2023 | June 30, 2027 | FREDRICKS, DAVID NEAL | reporter.nih.gov |
| Novel Strategies to Improve Blood Transfusion Practice | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $5,119,758 | August 15, 2022 | July 31, 2027 | LUO, HONGBO R | reporter.nih.gov |
| Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $5,093,143 | September 1, 2023 | August 31, 2028 | LAGIER-TOURENNE, CLOTILDE | reporter.nih.gov |
| A Precision Medicine Approach for the Study of Targetable Pathways in Vascular Dementia | NIH | National Institute on Aging | 2022 to 2025 | $5,086,657 | February 1, 2022 | November 30, 2026 | GOATE, ALISON M | reporter.nih.gov |
| Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,079,600 | March 6, 2019 | February 28, 2026 | KNOLLMANN, BJORN C | reporter.nih.gov |
| UCLA High-Throughput Neuropsychiatric Disorder Phenotyping Center (UCLA HT-NPC) | NIH | National Institute of Mental Health | 2023 to 2025 | $5,035,081 | May 1, 2023 | April 30, 2028 | GESCHWIND, DANIEL H | reporter.nih.gov |
| Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $5,032,505 | September 21, 2024 | July 31, 2029 | JENQ, ROBERT | reporter.nih.gov |
| 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,023,972 | April 1, 2022 | March 31, 2029 | SHAW, BRONWEN | reporter.nih.gov |
| Novel vascular smooth muscle cell progenitors in development and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,999,830 | July 1, 2020 | June 30, 2027 | GREIF, DANIEL | reporter.nih.gov |
| Multiethnic genomic epigenomic and transcriptomic fine-mapping and functional validation analysis of schizophrenia and bipolar disorder risk loci | NIH | National Institute of Mental Health | 2021 to 2025 | $4,996,628 | January 1, 2021 | October 31, 2026 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Leveraging Natural Phenotypic Variations of Heterogenous ALS Populations-in-a-Dish to Enable Scalable Drug Discovery | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $4,949,698 | September 18, 2022 | August 31, 2027 | ICHIDA, JUSTIN KAWIKA | reporter.nih.gov |
| Gastroesophageal junction stem cells as the origin of Barretts esophagus and cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,948,268 | September 1, 2025 | August 31, 2027 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| Dose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,937,681 | May 6, 2022 | April 30, 2027 | SCOTT, JESSICA | reporter.nih.gov |
| Experimental Cellular Approaches to Genotype × Environment Interaction | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $4,934,544 | September 7, 2023 | August 31, 2028 | CURRAN, JOANNE E. | reporter.nih.gov |
| Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,890,555 | September 30, 2021 | July 31, 2026 | SANNA, PIETRO P | reporter.nih.gov |
| Investigating the heterogeneity and coordination of hematopoietic stem cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,840,269 | August 1, 2020 | July 31, 2027 | LU, RONG | reporter.nih.gov |
| Regulation of chromatin dynamics | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,836,313 | June 1, 2017 | May 31, 2027 | PETERSON, CRAIG L | reporter.nih.gov |
| Program to promote lung regeneration and block fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,819,926 | February 15, 2020 | February 14, 2026 | CHAPMAN, HAROLD A | reporter.nih.gov |
| Novel Stem Cell Immunotherapy for MDR-Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,800,190 | June 4, 2021 | May 31, 2026 | JAGANNATH, CHINNASWAMY | reporter.nih.gov |
| Establishing patient-derived iPSCs as a platform for discovery research in NAFLD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $4,780,391 | June 1, 2023 | March 31, 2028 | MAHER, JACQUELYN J. | reporter.nih.gov |
| Durable HIV Vaccine Targeting Mucosal Epithelium | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,751,308 | August 1, 2022 | July 31, 2027 | GAUDUIN, MARIE-CLAIRE ELISABETH | reporter.nih.gov |
| Defining mechanisms driving salivary gland regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $4,717,861 | September 18, 2018 | June 30, 2026 | KNOX, SARAH MONICA | reporter.nih.gov |
| Defining and Controlling Airway Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,706,100 | March 8, 2019 | February 28, 2026 | HOLTZMAN, MICHAEL J | reporter.nih.gov |
| Development of Innovative Resources to Advance MDS Research | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $4,661,966 | September 15, 2023 | July 31, 2028 | BLEAKLEY, MARIE | reporter.nih.gov |
| Heritable immunization of the white-footed mouse reservoir of Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,657,626 | September 1, 2021 | August 31, 2026 | ESVELT, KEVIN | reporter.nih.gov |
| Altering Cardiac Cell Fate for Heart Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,621,749 | January 13, 2021 | November 30, 2027 | QIAN, LI | reporter.nih.gov |
| Bcl-2 and Mcl-1 inhibition for induction of hematopoietic chimerism and renal allograft tolerance without myelosuppression in nonhuman primates | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,613,595 | June 3, 2022 | May 31, 2027 | KAWAI, TATSUO | reporter.nih.gov |
| Early to Late Events in Colorectal Neoplasia: Basic Biology to Clinical Implementation | NIH | National Cancer Institute | 2021 to 2025 | $4,608,771 | April 1, 2017 | July 31, 2031 | COFFEY, ROBERT J. | reporter.nih.gov |
| Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting | NIH | National Cancer Institute | 2021 to 2025 | $4,594,192 | September 1, 2021 | August 31, 2028 | STEIDL, ULRICH | reporter.nih.gov |
| Molecular Pathogenesis of Acute Myeloid Leukemia | NIH | National Cancer Institute | 2021 to 2025 | $4,591,274 | August 13, 2015 | June 30, 2029 | LEY, TIMOTHY J. | reporter.nih.gov |
| Cell signaling in development and regeneration | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,582,546 | May 6, 2016 | July 9, 2026 | JIANG, JIN | reporter.nih.gov |
| Mechanisms underlying gastric intestinal metaplasia and carcinogenesis | NIH | National Cancer Institute | 2022 to 2025 | $4,560,310 | September 20, 2022 | August 31, 2027 | RUSTGI, ANIL K | reporter.nih.gov |
| Therapeutic Targeting of Human AML Stem Cells | NIH | National Cancer Institute | 2021 to 2025 | $4,546,001 | September 8, 2020 | August 31, 2027 | JORDAN, CRAIG T. | reporter.nih.gov |
| Pathological Mechanisms of Human Cerebellar Malformations | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,519,501 | September 1, 2016 | June 30, 2028 | MILLEN, KATHLEEN JOYCE | reporter.nih.gov |
| Mechanisms of Developmental Myelination | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,505,832 | May 15, 2021 | April 30, 2029 | APPEL, BRUCE H | reporter.nih.gov |
| Functional Analysis of Epigenetic Complexes | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,411,981 | April 1, 2019 | February 28, 2029 | KINGSTON, ROBERT | reporter.nih.gov |
| A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,411,202 | December 21, 2016 | June 30, 2026 | SACHA, JONAH B. | reporter.nih.gov |
| Cell-cell interactions governing lung epithelial progenitor cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,407,300 | March 15, 2020 | January 31, 2027 | KIM, CARLA F. | reporter.nih.gov |
| Regulation of proliferation and differentiation in the male germ line adult stem cell lineage | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,349,146 | June 1, 2020 | May 31, 2030 | FULLER, MARGARET T | reporter.nih.gov |
| Elucidating Mechanism of Cardiac Fibrosis with Cell Village of Pooled Human iPSCs | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,345,357 | December 16, 2015 | May 31, 2028 | WU, JOSEPH C. | reporter.nih.gov |
| The TET-DNMT-ASXL1-OGT axis: relevance to clonal hematopoiesis, heterochromatin integrity and cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,334,400 | September 1, 2016 | August 31, 2031 | RAO, ANJANA | reporter.nih.gov |
| Mechanism of Epigenetic Inheritance | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,320,227 | September 1, 2016 | July 31, 2026 | ZHANG, ZHIGUO | reporter.nih.gov |
| Impact of Infection and Inflammation on Primitive Hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,290,831 | July 1, 2021 | June 30, 2028 | KING, KATHERINE YUDEH | reporter.nih.gov |
| Charting human islet maturation via combined soft nanoelectronics and single-cell spatial transcriptomics | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,276,659 | September 17, 2021 | May 31, 2027 | LIU, JIA | reporter.nih.gov |
| Data science approaches to autism: environmental modulators of the transcriptome and gene-x-environment interactions | NIH | Office of the Director, National Institutes of Health | 2025 | $4,255,873 | September 29, 2025 | September 28, 2028 | GESCHWIND, DANIEL H | reporter.nih.gov |
| Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,229,195 | September 1, 2021 | August 31, 2027 | SATTLER, RITA | reporter.nih.gov |
| Molecular Regulation of Progressive Pulmonary Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,220,741 | March 1, 2020 | February 28, 2027 | NOBLE, PAUL WESLEY | reporter.nih.gov |
| Pathogenic Mechanisms in Christianson Syndrome and NHE6-Related Disorders | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,197,634 | September 15, 2019 | June 30, 2029 | MORROW, ERIC M | reporter.nih.gov |
| MSC Exosome Treatment for BPD: Impact on Immunity and Lung Development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,182,213 | March 1, 2019 | February 28, 2027 | KOUREMBANAS, STELLA | reporter.nih.gov |
| High-throughput in vivo and in vitro functional and multi-omics screens of neuropsychiatric and neurodevelopmental disorder risk genes | NIH | National Institute of Mental Health | 2023 to 2025 | $4,152,990 | May 1, 2023 | April 30, 2028 | HOFFMAN, ELLEN J | reporter.nih.gov |
| Biospecimen procurement and tissue microarray manufacture for the CHTN | NIH | National Cancer Institute | 2021 to 2025 | $4,152,759 | April 1, 2019 | March 31, 2029 | MOSKALUK, CHRISTOPHER A. | reporter.nih.gov |
| Understanding the role of metabolism in cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,148,510 | September 10, 2019 | August 31, 2026 | VANDER HEIDEN, MATTHEW G. | reporter.nih.gov |
| Resolving complex alternative splicing of psychiatric disease genes using single-cell approaches | NIH | National Institute of Mental Health | 2021 to 2025 | $4,123,629 | August 5, 2021 | May 31, 2026 | FANG, GANG | reporter.nih.gov |
| Functional convergence following disruption of diverse genes associated with neurodevelopmental disorders | NIH | National Institute of Mental Health | 2021 to 2025 | $4,120,229 | May 20, 2021 | March 31, 2027 | BRENNAND, KRISTEN JENNIFER | reporter.nih.gov |
| Understanding the functional impacts of Aβ variants in Alzheimer's disease with human brain organoids | NIH | National Institute on Aging | 2022 to 2025 | $4,119,330 | August 1, 2022 | July 31, 2027 | WEN, ZHEXING | reporter.nih.gov |
| Neuronal ApoE Drives Selective Neurodegeneration in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $4,070,240 | August 1, 2021 | May 31, 2026 | HUANG, YADONG | reporter.nih.gov |
| Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,065,243 | March 15, 2021 | February 28, 2027 | DEBAUN, MICHAEL R. | reporter.nih.gov |
| Nuclear pore complex quality control in ALS/FTD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,005,112 | May 1, 2021 | April 30, 2026 | ROTHSTEIN, JEFFREY D | reporter.nih.gov |
| Base editing and prime editing for sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,000,055 | January 1, 2021 | June 30, 2030 | WEISS, MITCHELL J | reporter.nih.gov |
| Impact of chronic alcohol consumption on the functional and epigenetic landscapes of monocytes and their progenitors | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,998,523 | September 1, 2020 | August 31, 2029 | MESSAOUDI, ILHEM | reporter.nih.gov |
| Regulation of mRNA processing: Mechanisms and Consequences | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,993,090 | June 8, 2016 | May 31, 2026 | MANLEY, JAMES L. | reporter.nih.gov |
| Combining Targeted RIT and Synergistic Novel Agent-Renewal | NIH | National Cancer Institute | 2021 to 2025 | $3,984,924 | June 1, 2020 | May 31, 2027 | OROZCO, JOHNNIE JOSE | reporter.nih.gov |
| Engineered Stem Cells for Cardiac Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,984,462 | February 1, 2018 | March 31, 2027 | REGNIER, MICHAEL | reporter.nih.gov |
| Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models | NIH | National Institute on Aging | 2021 to 2025 | $3,970,571 | April 15, 2021 | December 31, 2026 | LI, BINGSHAN | reporter.nih.gov |
| Interrogating Complex Methylome Network with Integrated Chemical Biology Tools | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,968,800 | June 1, 2019 | May 31, 2029 | LUO, MINKUI | reporter.nih.gov |
| Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,964,079 | January 1, 2022 | December 31, 2028 | MAJKA, SUSAN M | reporter.nih.gov |
| Coronal Suture Development in Health and Disease | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,959,879 | September 20, 2021 | July 31, 2027 | HOLMES, GREG PETER | reporter.nih.gov |
| Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,911,609 | August 1, 2015 | July 31, 2028 | KAPUR, REUBEN | reporter.nih.gov |
| Impaired activity-dependent protein synthesis in dendrites and pathophysiology in tauopathy | NIH | National Institute on Aging | 2021 to 2025 | $3,904,840 | August 1, 2021 | July 31, 2027 | TRACY, TARA | reporter.nih.gov |
| Osteoarthritis Progression And Sensory Pathway Alterations | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,899,677 | May 1, 2013 | July 31, 2029 | MALFAIT, ANNE-MARIE | reporter.nih.gov |
| Multifunctional morphogens: patterning precision and mesoderm migration | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,886,095 | July 1, 2020 | August 31, 2029 | HEEMSKERK, IDSE JOANNES | reporter.nih.gov |
| Generation of a temporal, spatial, and molecular map of in situ hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,870,336 | September 15, 2022 | May 31, 2027 | CAMARGO, FERNANDO | reporter.nih.gov |
| Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,869,226 | May 1, 2018 | May 31, 2027 | WU, JOSEPH C. | reporter.nih.gov |
| T cells in the aging brain | NIH | National Institute on Aging | 2021 to 2025 | $3,850,998 | June 15, 2021 | March 31, 2027 | BRUNET, ANNE | reporter.nih.gov |
| Understanding Skin Tissue Repair in Live Mammals | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,829,886 | March 1, 2018 | August 31, 2027 | GRECO, VALENTINA | reporter.nih.gov |
| The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,815,411 | February 1, 2010 | April 30, 2028 | MISRA, SANJAY | reporter.nih.gov |
| Gaining insight into psychiatric disease by engineering piece by piece the human brain in vitro | NIH | National Institute of Mental Health | 2025 | $3,812,108 | August 1, 2015 | August 19, 2029 | PASCA, SERGIU | reporter.nih.gov |
| Harnessing Glycoproteomics and Glycomics to Understand Cardiac Biology and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,810,605 | February 1, 2021 | January 31, 2028 | GUNDRY, REBEKAH L. | reporter.nih.gov |
| TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,806,187 | April 1, 2021 | March 31, 2026 | CLEVELAND, DON W | reporter.nih.gov |
| Cell competition in pulmonary fibrosis and ARDS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,796,920 | August 20, 2022 | July 31, 2029 | DE LANGHE, STIJN PIET JOHAN | reporter.nih.gov |
| Develop AD Connectivity Maps with Human iPSC-Derived Brain Cells and their Use | NIH | National Institute on Aging | 2022 to 2025 | $3,748,222 | September 1, 2022 | May 31, 2027 | HUANG, YADONG | reporter.nih.gov |
| Modeling HIV Microglia-Associated Infection and Inflammation in a Chimeric Mouse Brain | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,747,870 | August 1, 2021 | May 31, 2027 | AKBARIAN, SCHAHRAM | reporter.nih.gov |
| Genomic and functional characterization of ASD and ID-associated MYT1L mutation | NIH | National Institute of Mental Health | 2021 to 2025 | $3,747,342 | December 1, 2020 | October 31, 2026 | KROLL, KRISTEN L | reporter.nih.gov |
| Ikaros regulation: study on hemo-lymphopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,733,682 | September 5, 2011 | March 31, 2029 | GEORGOPOULOS, KATIA | reporter.nih.gov |
| Cilia in Heart Development and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,728,670 | February 15, 2019 | January 31, 2026 | BRUECKNER, MARTINA | reporter.nih.gov |
| Cardiogenesis: Molecular Mechanisms | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,717,603 | January 10, 1997 | May 31, 2028 | SRIVASTAVA, DEEPAK | reporter.nih.gov |
| Live Imaging of Skin Regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,713,235 | September 7, 2012 | August 31, 2027 | GRECO, VALENTINA | reporter.nih.gov |
| "Corral and Kill" strategy for HIV eradication using MSC in an SIV model | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,712,736 | March 23, 2020 | February 28, 2030 | DANDEKAR, SATYA | reporter.nih.gov |
| Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,710,340 | September 1, 2023 | August 31, 2028 | WEISS, MITCHELL J | reporter.nih.gov |
| Epigenetic gene regulation in the germline | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,700,633 | July 5, 2021 | December 31, 2026 | NAMEKAWA, SATOSHI | reporter.nih.gov |
| Systematic Functional Interpretation of Regulatory Variants in Neuropsychiatric Disorders | NIH | National Institute of Mental Health | 2021 to 2025 | $3,689,169 | May 4, 2016 | January 31, 2027 | DUAN, JUBAO | reporter.nih.gov |
| Optimizing Hematopoietic Stem Cell Transplantation For The Treatment Of Hematological Malignancies | NIH | National Cancer Institute | 2021 to 2025 | $3,687,540 | September 7, 2017 | June 30, 2032 | DIPERSIO, JOHN F. | reporter.nih.gov |
| The role of ABI3 in Alzheimers disease | NIH | National Institute on Aging | 2021 to 2025 | $3,667,316 | September 30, 2021 | May 31, 2027 | KIM, JUNGSU | reporter.nih.gov |
| Single-Cell Transcriptional and Epigenomic Dissection to Identify Therapeutic Targets for ALS and FTD | NIH | National Institute on Aging | 2021 to 2025 | $3,657,244 | March 1, 2021 | November 30, 2026 | KELLIS, MANOLIS | reporter.nih.gov |
| Neurotoxic and neurodegenerative risks from chronic exposure to metal mixtures in e-cigarette aerosol | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,656,277 | September 8, 2021 | June 30, 2027 | RE, DIANE BERENGERE | reporter.nih.gov |
| Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention. | NIH | National Cancer Institute | 2021 to 2025 | $3,654,173 | April 5, 2021 | March 31, 2027 | CHAN, ANDREW T | reporter.nih.gov |
| Emulating Immune Dysregulation by Trisomy 21 in a Multi-Organ-on-a-Chip System | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,649,414 | September 20, 2021 | July 31, 2026 | HAJIPOURAN BENAM, KAMBEZ | reporter.nih.gov |
| Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,648,726 | August 15, 2015 | May 31, 2026 | SARANTOPOULOS, STEFANIE | reporter.nih.gov |
| Nuclear and Glial Dysfunction in Neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $3,647,532 | May 16, 2023 | April 30, 2031 | ROTHSTEIN, JEFFREY D | reporter.nih.gov |
| Defining gene regulatory networks driving cortical evolution and brain development | NIH | National Institute of Mental Health | 2021 to 2025 | $3,647,249 | July 1, 2021 | April 30, 2027 | DE LA TORRE-UBIETA, LUIS | reporter.nih.gov |
| FunGen-xQTL: Unraveling the genetic basis of molecular functions in Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $3,642,232 | August 5, 2025 | July 31, 2030 | WANG, GAO | reporter.nih.gov |
| Molecular strategies for early detection and targeting of cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,640,759 | August 12, 2015 | July 31, 2028 | REYA, TANNISHTHA | reporter.nih.gov |
| Systems genetics analysis of tumor evolution in the mouse | NIH | National Cancer Institute | 2021 to 2025 | $3,631,667 | June 1, 2017 | July 31, 2032 | BALMAIN, ALLAN | reporter.nih.gov |
| Immunovascular interactions in postoperative delirium superimposed on dementia (DSD). | NIH | National Institute on Aging | 2022 to 2025 | $3,624,866 | September 15, 2022 | August 31, 2027 | TERRANDO, NICCOLO | reporter.nih.gov |
| Latrophilin Function in Synapse Formation | NIH | National Institute of Mental Health | 2021 to 2025 | $3,624,291 | July 1, 2021 | April 30, 2026 | SUDHOF, THOMAS C. | reporter.nih.gov |
| Intranasal Treatment of Stem Cell-derived Extracellular Vesicles for Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $3,620,000 | August 1, 2022 | July 31, 2027 | SHETTY, ASHOK K | reporter.nih.gov |
| Targeting the NLRP3 Inflammasome to Mitigate Neuroinflammation and HIV Persistence in the CNS: Mechanisms and Therapeutic Strategies | NIH | National Institute of Mental Health | 2025 | $3,613,504 | September 22, 2025 | September 21, 2029 | SWARTZ, TALIA H | reporter.nih.gov |
| HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,601,018 | April 9, 2021 | March 31, 2027 | HSU, KATHARINE C | reporter.nih.gov |
| New technologies to identify molecular regulators of the human hippocampus neurogenic niche in healthy aging and Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $3,598,243 | May 15, 2022 | February 28, 2027 | DUPONT, MAURA BOLDRINI | reporter.nih.gov |
| Origin of Cortical Species-specific Distinctions | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,571,176 | April 1, 2025 | March 31, 2030 | RAKIC, PASKO | reporter.nih.gov |
| Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children | NIH | National Cancer Institute | 2021 to 2025 | $3,570,931 | August 5, 2021 | July 31, 2026 | BURRIDGE, PAUL W. | reporter.nih.gov |
| Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,569,593 | April 1, 2019 | April 30, 2027 | WU, JOSEPH C. | reporter.nih.gov |
| DNA transposons and alternative pre-mRNA splicing. | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,562,349 | June 15, 2016 | May 31, 2027 | RIO, DONALD C | reporter.nih.gov |
| Probing cytosolic nucleic acid sensing pathways in cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,548,978 | January 1, 2021 | December 31, 2026 | LAUGHNEY, ASHLEY MARIE | reporter.nih.gov |
| Reprogramming of mature SMCs to vascular progenitor cells: Focus on Vascular Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,548,396 | January 18, 2019 | June 30, 2027 | WEISER-EVANS, MARY CM | reporter.nih.gov |
| Preventing GVHD by inhibition of alloantigen presentation in the gut | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,543,040 | July 1, 2019 | June 30, 2027 | HILL, GEOFFREY ROGER | reporter.nih.gov |
| Ocular Immune Regulation by Mesenchymal Stem Cells | NIH | National Eye Institute | 2021 to 2025 | $3,542,949 | April 1, 2015 | September 14, 2028 | CHAUHAN, SUNIL K | reporter.nih.gov |
| Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $3,540,268 | July 1, 2022 | March 31, 2027 | ENIKOLOPOV, GRIGORI N | reporter.nih.gov |
| Inter- and Intra-cellular effects of cannabinoids, HIV and ART in the CNS | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,529,874 | August 1, 2020 | May 31, 2027 | JORDAN-SCIUTTO, KELLY L | reporter.nih.gov |
| Discovery and CRISPR validation of genetic factors associated with antipsychotic-induced weight gain and cardiometabolic risk | NIH | National Institute of Mental Health | 2021 to 2025 | $3,528,182 | February 12, 2021 | December 31, 2026 | NICOL, GINGER E | reporter.nih.gov |
| JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,524,489 | September 20, 2021 | May 31, 2027 | OLABISI, OPEYEMI AYODEJI | reporter.nih.gov |
| Impact of the Human Herpesvirus 6A (HHV6A) latency gene U94A on Alzheimer disease pathology | NIH | National Institute on Aging | 2021 to 2025 | $3,507,363 | September 30, 2021 | May 31, 2026 | MAYER-PROSCHEL, MARGOT | reporter.nih.gov |
| Craniofacial Morphogenesis in Prenatal Alcohol Exposure | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,497,846 | July 1, 1996 | August 31, 2029 | SMITH, SUSAN M. | reporter.nih.gov |
| A Long Noncoding RNA Amerliorates Periodontitis via Distinct Epigenetic Pathways | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,494,925 | December 1, 2020 | November 30, 2026 | CHEN, JAKE JINKUN | reporter.nih.gov |
| Biochemical and cellular mechanisms linking actin mutations to visceral myopathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,487,348 | September 28, 2021 | August 31, 2027 | HEUCKEROTH, ROBERT O | reporter.nih.gov |
| Identifying Relapse Predictors and Therapeutic Vulnerabilities in Ph+ and Ph-like Acute Lymphoblastic Leukemia | NIH | National Cancer Institute | 2025 | $3,480,276 | August 1, 2025 | July 31, 2029 | LOH, MIGNON LEE-CHEUN | reporter.nih.gov |
| Combination Adjuvants to Program Durable Immunity to Respiratory Viral and Fungal Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,479,164 | February 17, 2016 | April 30, 2027 | SURESH, MARULASIDDAPPA | reporter.nih.gov |
| Probing Heterogeneity of Alzheimer's Disease Using iPSCs | NIH | National Institute on Aging | 2021 to 2025 | $3,479,050 | July 15, 2018 | April 30, 2028 | YOUNG-PEARSE, TRACY L | reporter.nih.gov |
| Resolving the function of progranulin in lysosomal lipid metabolism and the etiology of Alzheimer's disease and frontotemporal dementia | NIH | National Institute on Aging | 2022 to 2025 | $3,471,933 | September 1, 2022 | August 31, 2027 | KUKAR, THOMAS L | reporter.nih.gov |
| Intensive tailored exercise training with NAD+ precursor supplementation to improve muscle mass and fitness in adolescent and young adult survivors of hematopoietic stem cell transplantation | NIH | National Cancer Institute | 2021 to 2025 | $3,469,202 | September 1, 2021 | August 31, 2027 | MOSTOUFI-MOAB, SOGOL | reporter.nih.gov |
| Defining mechanisms of disease and repair in a viral model of multiple sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $3,467,101 | May 1, 2020 | April 30, 2029 | LANE, THOMAS E | reporter.nih.gov |
| Randomized trial of viral specific T-cell infusion to prevent viral infection after hematopoietic stem cell transplant. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,457,708 | July 1, 2021 | April 30, 2027 | DAVIES, STELLA MARGARET | reporter.nih.gov |
| Cell Identity Determination in Human Brain: Somatic Mutation and Cell Lineage | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,434,150 | December 16, 1994 | June 30, 2030 | WALSH, CHRISTOPHER A. | reporter.nih.gov |
| Preserving physical function in patients with kidney disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,428,324 | August 3, 2021 | June 30, 2026 | ABRAMOWITZ, MATTHEW K | reporter.nih.gov |
| Chemical tools for developmental biology | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,426,216 | April 1, 2018 | June 30, 2028 | CHEN, JAMES K | reporter.nih.gov |
| Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,421,854 | February 15, 2016 | July 31, 2027 | RICE, CHARLES M | reporter.nih.gov |
| The Impact of the Bone Marrow Niche's Immune Privilege on Psoriatic Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,406,145 | August 8, 2025 | July 31, 2029 | FUJISAKI, JOJI | reporter.nih.gov |
| Remediating fibrosis for salivary gland regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,392,837 | April 1, 2019 | March 31, 2029 | LARSEN, MELINDA | reporter.nih.gov |
| Modeling functional genomics of susceptibility to the persistent effects of environmental toxins in an elderly rural Indiana neurodegenerative cohort | NIH | National Institute on Aging | 2022 to 2025 | $3,385,412 | September 15, 2022 | May 31, 2027 | BOWMAN, AARON B | reporter.nih.gov |
| Developmental origins and homeostatic mechanisms underlying adult phenotypes | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,384,344 | May 1, 2017 | April 30, 2027 | PARICHY, DAVID M | reporter.nih.gov |
| Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,369,470 | July 7, 2016 | December 31, 2029 | WILLIAMS, DAVID A | reporter.nih.gov |
| Nanoscale probes for sensing molecular functions in live cells | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,364,334 | June 1, 2021 | May 31, 2027 | CUI, BIANXIAO | reporter.nih.gov |
| Regulation of Hemoglobin Switching | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,354,270 | August 5, 2013 | January 31, 2027 | BLOBEL, GERD A | reporter.nih.gov |
| Cellular and molecular mechanisms underlying DDX3X syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,350,844 | January 1, 2021 | November 30, 2026 | SILVER, DEBRA L. | reporter.nih.gov |
| Dystrophin Replacement | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,349,499 | April 1, 1991 | April 30, 2026 | CHAMBERLAIN, JEFFREY S | reporter.nih.gov |
| Unraveling the molecular pathology of retinal degeneration through single cell genomics | NIH | National Eye Institute | 2021 to 2025 | $3,347,817 | June 1, 2021 | May 31, 2027 | AYYAGARI, RADHA | reporter.nih.gov |
| Elucidating Anthracycline-Induced Cell Type-Specific Cardiovascular Toxicity with CRISPRi/a Screens | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,345,164 | September 1, 2025 | August 31, 2030 | WU, JOSEPH C. | reporter.nih.gov |
| Role of Energy Metabolism in Patterning the Vertebrate Musculo-Skeletal Axis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,337,554 | March 1, 2016 | March 31, 2026 | POURQUIE, OLIVIER | reporter.nih.gov |
| Regulation of Progenitor Cell Plasticity in Lung Development and Disease-Repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,331,553 | July 1, 2023 | June 30, 2030 | CARDOSO, WELLINGTON V. | reporter.nih.gov |
| Why do Down Syndrome patients have high risk of Hirschsprung disease? | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,330,453 | September 15, 2022 | July 31, 2027 | CHAKRAVARTI, ARAVINDA | reporter.nih.gov |
| Engineering synthetic immune cells with modular sentinel and therapeutic functions for T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,328,254 | April 1, 2022 | September 30, 2026 | LIM, WENDELL A | reporter.nih.gov |
| Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,324,533 | August 1, 2018 | June 30, 2027 | WU, JOSEPH C. | reporter.nih.gov |
| Investigating aberrant vesicular degradation and lipid metabolism in neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $3,323,710 | August 15, 2025 | July 31, 2029 | BOSCO, DARYL ANGELA | reporter.nih.gov |
| The Primate Corticospinal Connectome and Transcriptome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,321,910 | September 15, 2017 | May 31, 2026 | TUSZYNSKI, MARK H. | reporter.nih.gov |
| Leveraging 3D bioprinted organoid constructs to pattern and model human brain development | NIH | National Institute of Mental Health | 2021 to 2025 | $3,321,612 | April 1, 2021 | January 31, 2026 | SLOAN, STEVEN A | reporter.nih.gov |
| Novel Mechanisms of Exercise Training Effects on Glucose Homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,320,917 | April 10, 2014 | December 31, 2028 | GOODYEAR, LAURIE J | reporter.nih.gov |
| Immunobiology of the normal and injured lung | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,312,758 | January 1, 2022 | December 31, 2028 | LOONEY, MARK ROBERTS | reporter.nih.gov |
| Versatile, exponentially scalable methods for single cell molecular profiling | NIH | National Human Genome Research Institute | 2021 to 2025 | $3,289,666 | September 15, 2019 | April 30, 2028 | SHENDURE, JAY ASHOK | reporter.nih.gov |
| Proteogenetics of Autism Spectrum Disorders | NIH | National Institute of Mental Health | 2021 to 2025 | $3,288,305 | August 1, 2013 | June 30, 2027 | YATES III, JOHN R | reporter.nih.gov |
| Extracellular Vesicle treatment and age-related neuropathology in non-human primates | NIH | National Institute on Aging | 2025 | $3,284,677 | September 15, 2020 | August 31, 2029 | MOORE, TARA L | reporter.nih.gov |
| Decoding innate immune signaling in normal and myelodysplastic hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,283,833 | January 1, 2023 | December 31, 2029 | STARCZYNOWSKI, DANIEL | reporter.nih.gov |
| The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia | NIH | National Cancer Institute | 2022 to 2025 | $3,273,998 | September 1, 2022 | August 31, 2027 | ABRAMS, JULIAN | reporter.nih.gov |
| Development of novel genomic approaches for profiling cellular temporal-spatial dynamics of neurogenesis in Aging and Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $3,270,531 | June 1, 2022 | February 28, 2027 | CAO, JUNYUE | reporter.nih.gov |
| Histone lactylation pathway in hair cycle: deacylases and their protein targets | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,263,621 | July 1, 2021 | April 30, 2026 | ZHAO, YINGMING | reporter.nih.gov |
| Mechanisms of Beta Cell Failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,260,500 | July 1, 2003 | July 31, 2026 | ACCILI, DOMENICO | reporter.nih.gov |
| Identification of enteric Juvenile Protective Factors and their role in stimulating neurogenesis in the adult and ageing Enteric Nervous System | NIH | National Institute on Aging | 2021 to 2025 | $3,254,354 | January 15, 2021 | December 31, 2026 | GOFF, LOYAL ANDREW | reporter.nih.gov |
| Genetic Studies of Cortex Structure and Development | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,251,011 | September 30, 2016 | June 30, 2026 | RUBENSTEIN, JOHN L. R. | reporter.nih.gov |
| A spatial view of hematopoietic regeneration dynamics in the bone marrow | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,245,428 | September 15, 2024 | July 31, 2029 | LU, RONG | reporter.nih.gov |
| Design, prediction, and prioritization of systematic perturbations of the human genome | NIH | National Human Genome Research Institute | 2021 to 2025 | $3,243,707 | September 1, 2021 | May 31, 2027 | ALLEN, ANDREW S | reporter.nih.gov |
| Genetically Programmed Pancreatic Organoids with Self-Adaptive Multi-Lineage Population Control | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,243,464 | September 1, 2021 | August 31, 2026 | WEISS, RON | reporter.nih.gov |
| TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease | NIH | National Institute on Aging | 2022 to 2025 | $3,240,062 | July 15, 2022 | March 31, 2027 | CHENG, FEIXIONG | reporter.nih.gov |
| Multi-Targeting Oligonucleotide Therapeutics for Familial and Sporadic Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,236,744 | May 15, 2019 | May 31, 2029 | WATTS, JONATHAN K | reporter.nih.gov |
| Genetic and Structural Basis for Virus Neutralization of Paramyxoviruses | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,230,785 | September 16, 2024 | September 15, 2027 | reporter.nih.gov | |
| Targeting innate immunity for induction of robust renal allograft tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,224,166 | July 25, 2023 | April 30, 2028 | KAWAI, TATSUO | reporter.nih.gov |
| Targeting HIV-specific T cell differentiation programs to enhance post-treatment control of HIV | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,224,130 | January 19, 2022 | December 31, 2026 | RUTISHAUSER, RACHEL LENA | reporter.nih.gov |
| Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,223,525 | December 7, 2020 | November 30, 2026 | KUKURUZINSKA, MARIA A. | reporter.nih.gov |
| Developing second generation SCID pig models: filling the gaps to improve translation of therapeutics in regenerative medicine | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $3,219,338 | February 15, 2020 | July 31, 2029 | TUGGLE, CHRISTOPHER | reporter.nih.gov |
| Regulation of Epidermal Development and Differentiation-Renewal | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,204,420 | January 1, 1983 | May 31, 2026 | FUCHS, ELAINE | reporter.nih.gov |
| Reprogramming and Directed Differentiation of Skeletal Muscle Cells from hPSCs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,204,262 | September 20, 2013 | June 30, 2028 | PYLE, APRIL D | reporter.nih.gov |
| Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,203,281 | April 1, 2021 | March 31, 2027 | STUDER, LORENZ P. | reporter.nih.gov |
| Novel Molecular Biomarkers of Bone Microarchitecture | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,202,138 | September 30, 1991 | March 31, 2027 | KIEL, DOUGLAS P. | reporter.nih.gov |
| Roles and regulation of tissue resident CD8 T cells during a persistent viral infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,194,992 | July 16, 2025 | June 30, 2029 | ZUNIGA, ELINA I | reporter.nih.gov |
| Mechanism of chromatin accessibility, 3D chromosome organization, and their functions in gene regulation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,190,319 | January 1, 2021 | December 31, 2026 | BAI, LU | reporter.nih.gov |
| Assessing Effects of Microgravity on Cardiovascular Aging with AI and 3D Organoids | NIH | National Center for Advancing Translational Sciences | 2025 | $3,183,188 | August 1, 2025 | June 30, 2028 | WU, JOSEPH C. | reporter.nih.gov |
| Regulation of Growth and Morphogenesis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,183,036 | May 1, 2019 | April 30, 2029 | IRVINE, KENNETH D | reporter.nih.gov |
| Progenitors, Mechanisms of Differentiation, and Functions of Lung M Cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,180,672 | August 1, 2022 | July 31, 2026 | RAJAGOPAL, JAYARAJ | reporter.nih.gov |
| Developing preclinical xenograft models in zebrafish. | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $3,178,512 | March 1, 2022 | February 28, 2026 | LANGENAU, DAVID MICHAEL | reporter.nih.gov |
| Single-cell Multi-omic Profiling of Drug Responses Using Pooled iPSC-CM Differentiation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,175,574 | May 1, 2019 | April 30, 2027 | WU, JOSEPH C. | reporter.nih.gov |
| Autologous BM-MSCs and Islet Co-transplantation to Enhance Islet Survival and Function in TP-IAT Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,169,762 | August 24, 2021 | May 31, 2027 | WANG, HONGJUN | reporter.nih.gov |
| Hematopoietic Stem Cell And Cord Blood Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,169,146 | September 30, 2005 | May 31, 2030 | PETERSDORF, EFFIE W | reporter.nih.gov |
| Microphysiological Model of Human Cardiac Sympathetic Innervation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,165,021 | July 1, 2022 | June 30, 2027 | KIM, DEOK-HO | reporter.nih.gov |
| Advancing Targeted Therapies for Cushing's Disease Using Pituitary Neuroendocrine Tumor Organoids | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,162,826 | September 12, 2025 | August 31, 2029 | ZAVROS, YANA | reporter.nih.gov |
| Cellular Reinnervation Therapy for Vocal Fold Paralysis | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,161,418 | August 4, 2021 | May 31, 2027 | HALUM, STACEY L. | reporter.nih.gov |
| Immunomodulation by splenic megakaryocytes and platelets in sepsis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,151,437 | June 7, 2022 | May 31, 2027 | LOONEY, MARK ROBERTS | reporter.nih.gov |
| A new brain organoid model for NeuroHIV and the impact of opioids | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,149,557 | September 30, 2022 | August 31, 2027 | MUOTRI, ALYSSON R. | reporter.nih.gov |
| Engineering Vascularized Cardiac Muscle | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,149,452 | July 1, 2005 | March 31, 2027 | VUNJAK-NOVAKOVIC, GORDANA | reporter.nih.gov |
| Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism | NIH | National Institute of Mental Health | 2022 to 2025 | $3,142,634 | March 5, 2022 | December 31, 2026 | MUOTRI, ALYSSON R. | reporter.nih.gov |
| Harnessing Novel Human Endocrine Progenitor Biology for Enhanced Generation of Beta Cells from Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,140,632 | September 1, 2025 | August 31, 2029 | SNEDDON, JULIE BETH | reporter.nih.gov |
| Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,134,067 | June 1, 2019 | March 31, 2027 | WANG, HONGJUN | reporter.nih.gov |
| Correlating molecular behavioral phenotypes in a marmoset model of Huntingtons disease | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,130,636 | August 1, 2021 | May 31, 2026 | BRIVANLOU, ALI H | reporter.nih.gov |
| A DUAL CHIMERIC HUMAN ASTROGLIAL-MICROGLIAL MODEL OF HIV AND HAND | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,125,946 | August 1, 2021 | May 31, 2026 | GOLDMAN, STEVEN ALAN | reporter.nih.gov |
| PFAS exposure is detrimental to placental function and fetal development by disrupting mitochondrial function and metabolism | NIH | National Institute of Environmental Health Sciences | 2025 | $3,121,590 | September 5, 2025 | September 4, 2029 | FENG, LIPING | reporter.nih.gov |
| Parametric Response Mapping (PRM) for the detection of chronic lung injury in hematopoietic cell transplant recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,121,383 | August 15, 2022 | July 31, 2026 | YANIK, GREGORY A | reporter.nih.gov |
| Defective heme transport in the development of congenital hydrocephalus | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,120,419 | September 1, 2021 | June 30, 2026 | ARNOLD, THOMAS DARMODY | reporter.nih.gov |
| Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation | NIH | National Cancer Institute | 2021 to 2025 | $3,120,296 | August 1, 2021 | July 31, 2027 | HAHN, THERESA E | reporter.nih.gov |
| Establishment of a causal link between AD and L1 retrotransposons | NIH | National Institute on Aging | 2022 to 2025 | $3,120,084 | September 15, 2022 | July 31, 2027 | MUOTRI, ALYSSON R. | reporter.nih.gov |
| ASH1L mediated transcription networks in autism spectrum disorders | NIH | National Institute of Mental Health | 2023 to 2025 | $3,119,859 | January 1, 2023 | December 31, 2026 | LIZARRAGA, SOFIA BEATRIZ | reporter.nih.gov |
| Gvl mHA Specific T Cell Responses Prevent AML Relapse Following Allogeneic Stem Cell Transplantation. | NIH | National Cancer Institute | 2021 to 2025 | $3,119,515 | July 1, 2020 | June 30, 2027 | VINCENT, BENJAMIN G | reporter.nih.gov |
| Penetrating the “Black box”: Prediction of early Bronchiolitis obliterans in Pediatric Hematopoietic Stem Cell Transplant Recipients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,117,523 | July 15, 2021 | April 30, 2027 | MYERS, KASIANI | reporter.nih.gov |
| Neural stem cell rejuvenation through single cell pharmacogenomics | NIH | National Institute on Aging | 2022 to 2025 | $3,117,021 | June 15, 2022 | February 28, 2027 | BONAGUIDI, MICHAEL | reporter.nih.gov |
| Hippocampal iPSC-Derived Assembloids to Model Interneuron and Circuit Vulnerability in Genetically-Encoded Amnestic and Behavioral Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $3,109,857 | August 1, 2025 | July 31, 2029 | REXACH, JESSICA E | reporter.nih.gov |
| Neuronal Autophagy: a Cell-Autonomous Protection Mechanism | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,106,444 | April 1, 2008 | January 31, 2028 | YUE, ZHENYU | reporter.nih.gov |
| Mechanisms that couple irregular development of fetal melanoblasts to premature exhaustion of adult melanocyte stem cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,102,648 | August 4, 2021 | May 31, 2027 | ADAMS, PETER D. | reporter.nih.gov |
| A beneficial persistent DNA damage-induced immune response in aging | NIH | National Institute on Aging | 2025 | $3,101,237 | September 1, 2025 | August 31, 2029 | DU, WEI | reporter.nih.gov |
| Vascularized NICHE with local immunosuppression for cell replacement for Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,096,729 | September 12, 2022 | May 31, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Functional Characterization of LncRNAs Involved in Pluripotency or Differentiation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,095,040 | August 20, 2019 | March 31, 2030 | SPECTOR, DAVID L | reporter.nih.gov |
| Development of iPSCs for comparative genomics in primates | NIH | National Human Genome Research Institute | 2021 to 2025 | $3,092,654 | September 1, 2019 | April 30, 2027 | GILAD, YOAV | reporter.nih.gov |
| Lineage Progression of Cortical Neural Stem Cells | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,090,762 | May 15, 2015 | July 31, 2027 | CHEN, BIN | reporter.nih.gov |
| Pathogenic monocyte response to chronic lung inflammation in cystic fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,086,283 | January 1, 2022 | November 30, 2026 | BRUSCIA, EMANUELA MARINA | reporter.nih.gov |
| Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,081,005 | December 1, 2021 | November 30, 2025 | FUJISAKI, JOJI | reporter.nih.gov |
| Anti-inflammatory Cell Based Repair of Intervertebral Disc Degeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,075,117 | September 1, 2021 | August 31, 2026 | CHAHINE, NADEEN O. | reporter.nih.gov |
| Mechanisms and Function of Myonuclear Positioning | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,074,996 | September 1, 2014 | January 31, 2027 | BAYLIES, MARY K | reporter.nih.gov |
| BIOLOGICAL EMBEDDING OF CONTEXTUAL FACTORS IN HUMAN STEM CELLS: IMPLICATIONS FOR POPULATION HEALTH DIFFERENCES | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $3,074,250 | September 26, 2022 | June 30, 2027 | WADHWA, PATHIK D | reporter.nih.gov |
| Mechanism of stathmin-2-dependent axon maintenance, regeneration, and function | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $3,072,075 | April 1, 2020 | March 31, 2029 | CLEVELAND, DON W | reporter.nih.gov |
| A transdisciplinary approach for dissecting stem cell states in prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,070,312 | September 20, 2021 | August 31, 2026 | RABADAN, RAUL | reporter.nih.gov |
| Role of the Cell Death Machinery in a Somatic Autoinflammatory Syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,066,524 | August 21, 2025 | July 31, 2029 | GITLIN, ALEXANDER | reporter.nih.gov |
| Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance | NIH | National Cancer Institute | 2021 to 2025 | $3,062,772 | September 22, 2021 | August 31, 2026 | MUNN, LANCE L. | reporter.nih.gov |
| First Aid Medicine to Treat Vesicant Induced Corneal Injury | NIH | National Eye Institute | 2022 to 2025 | $3,055,554 | September 30, 2022 | August 31, 2027 | CHANDLER, HEATHER | reporter.nih.gov |
| Molecular and Cellular Basis of Craniosynostosis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,051,443 | July 1, 2016 | July 31, 2026 | CRUMP, GAGE D | reporter.nih.gov |
| Microengineering vascularized and innervated bone-like scaffolds as an alternative to autologous bone grafts | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,048,776 | August 1, 2021 | April 30, 2027 | BERTASSONI, LUIZ EDUARDO | reporter.nih.gov |
| Using MR Spectroscopy to Measure Mammalian Neurogenesis in Vivo | NIH | National Institute on Aging | 2022 to 2025 | $3,042,523 | June 1, 2022 | February 28, 2027 | MALETIC-SAVATIC, MIRJANA | reporter.nih.gov |
| The emerging role of apelin, RAAS, and ACE2 crosstalk in pulmonary hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,037,281 | August 1, 2022 | July 31, 2027 | FRUMP, ANDREA LEE | reporter.nih.gov |
| Control of cell proliferation and differentiation by growth pathways | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,036,731 | May 1, 2019 | April 30, 2029 | FROLOV, MAXIM | reporter.nih.gov |
| Hippocampal neurogenesis in cognitive function and dysfunction in Alzheimer's disease. | NIH | National Institute on Aging | 2022 to 2025 | $3,035,322 | May 15, 2022 | April 30, 2027 | LAZAROV, ORLY | reporter.nih.gov |
| Assessing Genomic, Regulatory and Transcriptional Variation at Single Nuclei Resolution in the Brains of Individuals with Autism Spectrum Disorder | NIH | National Institute of Mental Health | 2021 to 2025 | $3,034,663 | July 27, 2021 | May 31, 2027 | NOWAKOWSKI, TOMASZ | reporter.nih.gov |
| Molecular Drivers of Human Gliogenesis | NIH | National Institute of Mental Health | 2021 to 2025 | $3,033,949 | August 1, 2021 | May 31, 2026 | SLOAN, STEVEN A | reporter.nih.gov |
| Early cardiac progenitors | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,025,531 | July 1, 2013 | July 31, 2029 | BRUNEAU, BENOIT GAETAN | reporter.nih.gov |
| Modeling Inner Ear Differentiation with Pluripotent Stem Cells | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,024,653 | March 1, 2014 | May 31, 2029 | HASHINO, ERI | reporter.nih.gov |
| Heightened hypoxia and DNA methylation in heart defects of diabetic embryopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,020,733 | September 15, 2022 | July 31, 2027 | YANG, PEIXIN | reporter.nih.gov |
| Development of ultra-efficient antibodies for single cell mapping applications | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,018,104 | March 10, 2023 | February 28, 2026 | JOHNSTONE, ANDREA LYNN | reporter.nih.gov |
| Mechanisms and rescue of craniosynostosis associated with gene-environment interaction | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,011,888 | July 1, 2021 | April 30, 2027 | CHEN, JIANFU | reporter.nih.gov |
| Engineering multi-lineage inner ear organoids | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,010,274 | December 1, 2018 | June 30, 2025 | KOEHLER, KARL RUSSELL | reporter.nih.gov |
| Cell-Type Specific Mechanisms of Mitral Valve Prolapse | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,008,247 | September 1, 2025 | August 31, 2029 | CHI, NEIL C | reporter.nih.gov |
| Generating Exogenic Organs for Transplantation without the Use of Immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,005,890 | September 21, 2022 | July 31, 2027 | STEER, CLIFFORD JOHN | reporter.nih.gov |
| Mechanisms of T Cell Quiescence and Exhaustion | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,001,713 | March 1, 2019 | February 28, 2029 | SARKAR, SUROJIT | reporter.nih.gov |
| In vivo Characterization of Regulatory Variant Pathogenicity in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,998,900 | January 1, 2022 | December 31, 2026 | VISEL, AXEL | reporter.nih.gov |
| Pax6 as a key regulator of lens development | NIH | National Eye Institute | 2021 to 2025 | $2,996,871 | January 1, 2000 | May 31, 2026 | CVEKL, ALES | reporter.nih.gov |
| (PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis | NIH | National Cancer Institute | 2021 to 2025 | $2,993,160 | April 8, 2021 | March 31, 2027 | SHEMBADE, NOULA DATTU | reporter.nih.gov |
| Targeting MicroRNAs to Eradicate Leukemia Stem Cells | NIH | National Cancer Institute | 2021 to 2025 | $2,990,517 | August 1, 2017 | July 31, 2027 | KUO, YA-HUEI | reporter.nih.gov |
| Role of an Aberrant N6-Methyladenosine-LncRNA Axis in the Development and Maintenance of Drug Resistance through Regulating the Leukemia Stem Cell | NIH | National Cancer Institute | 2022 to 2025 | $2,988,832 | September 12, 2022 | August 31, 2027 | LIU, SHUJUN | reporter.nih.gov |
| Adhesion GPCR regulation of acute myeloid leukemia stem cells - Resubmission - 1 | NIH | National Cancer Institute | 2021 to 2025 | $2,988,590 | March 1, 2021 | February 28, 2026 | PARK, CHRISTOPHER Y | reporter.nih.gov |
| Adhesion G Protein-Coupled Receptors in CNS Development and Regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,987,194 | September 30, 2015 | May 31, 2027 | PIAO, XIANHUA | reporter.nih.gov |
| Targeting TET DNA Dioxygenases as Therapeutic Principle in Myeloid Neoplasms | NIH | National Cancer Institute | 2021 to 2025 | $2,986,870 | July 1, 2021 | June 30, 2026 | MACIEJEWSKI, JAROSLAW P. | reporter.nih.gov |
| Unraveling the Genetic Programs Engaged in ASD Neurons Through Coupled Transcriptomic and Phenotypic Readouts | NIH | National Institute of Mental Health | 2022 to 2025 | $2,986,134 | August 10, 2022 | June 30, 2027 | FARHI, SAMOUIL | reporter.nih.gov |
| Stem Cell and Transplantation Biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,984,057 | August 1, 2015 | July 31, 2028 | STIREWALT, DEREK L | reporter.nih.gov |
| Genetically-engineered stem cells for self-regulating arthritis therapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,983,611 | April 1, 2022 | March 31, 2027 | GUILAK, FARSHID | reporter.nih.gov |
| Blood vessel assembly from multipotent hemangioma-derived stem cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,982,138 | April 1, 2009 | April 30, 2028 | BISCHOFF, JOYCE E. | reporter.nih.gov |
| Investigating the role of Alzheimer's disease familial mutations in neuromuscular physiology | NIH | National Institute on Aging | 2022 to 2025 | $2,980,194 | May 15, 2022 | April 30, 2027 | HICKMAN, JAMES J | reporter.nih.gov |
| Specialized Translational Control of Stem Cell Differentiation and Embryonic Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,979,836 | March 15, 2016 | March 31, 2026 | BARNA, MARIA | reporter.nih.gov |
| Alzheimer's Disease associated pathology induced by neurotropic viral infection | NIH | National Institute on Aging | 2021 to 2025 | $2,972,109 | September 30, 2021 | August 31, 2027 | MURPHY, EAIN A | reporter.nih.gov |
| Integration and functionality of retinal organoid transplants | NIH | National Eye Institute | 2021 to 2025 | $2,971,351 | May 1, 2021 | March 31, 2027 | SEILER, MAGDALENE J | reporter.nih.gov |
| Developmental programming of adult stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,970,076 | September 15, 2025 | September 14, 2029 | MANA, MIYEKO | reporter.nih.gov |
| Defining the role of histone H3K4 mono-methyltransferase dysfunction in urothelial carcinoma | NIH | National Cancer Institute | 2022 to 2025 | $2,969,354 | September 1, 2025 | August 31, 2027 | CHEN, YU | reporter.nih.gov |
| Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,966,978 | December 1, 2021 | November 30, 2026 | CHENG, GUANG-SHING | reporter.nih.gov |
| Systems biology of intratumoral heterogeneity in glioblastoma | NIH | National Cancer Institute | 2022 to 2025 | $2,962,426 | January 1, 2022 | December 31, 2026 | BALIGA, NITIN S | reporter.nih.gov |
| Cell Fate Decisions in Epithelial Stem Cell Lineages | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,957,506 | July 1, 2020 | May 31, 2030 | NYSTUL, TODD | reporter.nih.gov |
| Therapeutic Targets for Niemann-Pick Type C Neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,954,773 | August 15, 2021 | July 31, 2026 | LIEBERMAN, ANDREW P | reporter.nih.gov |
| Preclinical studies of pluripotent stem cell-derived myogenic progenitors in non-human primates | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,948,443 | August 6, 2021 | December 31, 2026 | PERLINGEIRO, RITA C. R. | reporter.nih.gov |
| Defining the cause and consequence of aging-specific platelet specification from hematopoietic stem cells | NIH | National Institute on Aging | 2021 to 2025 | $2,943,876 | September 15, 2019 | May 31, 2029 | FORSBERG, CAMILLA | reporter.nih.gov |
| Clonal hematopoiesis, inflammasomes and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,941,081 | February 15, 2021 | January 31, 2029 | TALL, ALAN RICHARD | reporter.nih.gov |
| Regulation of hematopoiesis by ribosomal protein paralogs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,934,669 | February 1, 2025 | January 31, 2030 | WIEST, DAVID L. | reporter.nih.gov |
| Backtracking Leukemia-Typical Somatic Alterations in Cord Blood at Single-cell Resolution | NIH | National Cancer Institute | 2021 to 2025 | $2,927,357 | August 1, 2021 | July 31, 2026 | SPECTOR, LOGAN G. | reporter.nih.gov |
| Specification, Molecular Control and Niche Functions of the Hair Follicle Mesenchyme | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,922,092 | September 15, 2016 | August 31, 2026 | RENDL, MICHAEL | reporter.nih.gov |
| Tissue Engineered Rostral Migratory Stream for Directed Neuronal Replacement | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,919,684 | April 1, 2021 | March 31, 2026 | CULLEN, DANIEL KACY | reporter.nih.gov |
| Mechanisms of epitranscriptomic regulation in cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,917,446 | September 10, 2014 | August 31, 2029 | JAFFREY, SAMIE R | reporter.nih.gov |
| Modeling myelodysplasia | NIH | National Cancer Institute | 2021 to 2025 | $2,916,597 | January 1, 2021 | December 31, 2026 | GRIMES, H. LEIGHTON | reporter.nih.gov |
| RIGERR: Resources for Investigating Genetic and Epigenetic Regulation of Renal Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,915,414 | August 3, 2023 | July 31, 2027 | LIANG, MINGYU | reporter.nih.gov |
| Identification of metabolic alterations during cortical development in a human cellular model for 22q11.2 deletion syndrome | NIH | National Institute of Mental Health | 2022 to 2025 | $2,912,854 | January 18, 2022 | October 31, 2026 | PASCA, ANCA MIRABELA | reporter.nih.gov |
| RNAi-dependent epimutation roles in antimicrobial drug resistance and pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,911,488 | July 1, 2022 | June 30, 2027 | HEITMAN, JOSEPH | reporter.nih.gov |
| iPSC-Derived Vascularized Human Lung Organoids and Interaction Between Lung Endothelial Cells and Alveolar Epithelial Cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,907,792 | August 1, 2022 | May 31, 2027 | REHMAN, JALEES | reporter.nih.gov |
| Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation | NIH | National Institute on Aging | 2021 to 2025 | $2,907,195 | September 15, 2021 | June 30, 2027 | TROWBRIDGE, JENNIFER JEAN | reporter.nih.gov |
| iSTAR Tregs | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,906,574 | July 1, 2023 | June 30, 2027 | TANG, QIZHI | reporter.nih.gov |
| The DNA damage response of fast-cycling erythroblasts | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,899,464 | August 25, 2021 | October 31, 2026 | SOCOLOVSKY, MERAV | reporter.nih.gov |
| Alterations in Post-Receptor Insulin Signaling in Diabetes and Insulin Resistance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,895,718 | September 17, 2021 | June 30, 2027 | KAHN, C RONALD | reporter.nih.gov |
| Dissecting Yersinia Yop Targets in Neutrophils | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,883,504 | February 11, 2022 | January 31, 2027 | MECSAS, JOAN C | reporter.nih.gov |
| Elucidating the molecular mechanisms behind human neurodevelopmental disorders using brain organoids | NIH | National Institute of Mental Health | 2022 to 2025 | $2,876,812 | February 16, 2022 | December 31, 2026 | NOVITCH, BENNETT G | reporter.nih.gov |
| Metabolic control of normal and malignant hematopoiesis | NIH | National Cancer Institute | 2021 to 2025 | $2,869,404 | September 1, 2020 | May 31, 2027 | INTLEKOFER, ANDREW MICHAEL | reporter.nih.gov |
| WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,862,721 | September 10, 2021 | August 31, 2026 | LEE, BRENDAN | reporter.nih.gov |
| Neurotropic herpesvirus envelopment and microtubule-mediated transport | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,862,658 | March 15, 2017 | November 30, 2027 | WILSON, DUNCAN W. | reporter.nih.gov |
| In Vivo Prevention of Murine GVHD | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,859,522 | July 1, 2022 | June 30, 2027 | BLAZAR, BRUCE R | reporter.nih.gov |
| Uncovering mechanisms of protection from Alzheimer's disease in CHIP using human cohorts and biosamples | NIH | National Institute on Aging | 2024 to 2025 | $2,857,034 | September 17, 2024 | May 31, 2029 | JAISWAL, SIDDHARTHA | reporter.nih.gov |
| Functional Determinants of Metastatic Dormancy | NIH | National Cancer Institute | 2021 to 2025 | $2,856,382 | January 12, 2022 | June 30, 2026 | AGUIRRE-GHISO, JULIO A. | reporter.nih.gov |
| Molecular genetic analyses of transcriptional dysregulation in Alzheimers disease | NIH | National Institute on Aging | 2022 to 2025 | $2,855,753 | July 15, 2022 | March 31, 2027 | KIM, JUNGSU | reporter.nih.gov |
| New upstream targets for HIF-1a-mediated regeneration in young and aged animals | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,854,411 | May 1, 2011 | May 31, 2027 | HEBER-KATZ, ELLEN S. | reporter.nih.gov |
| Investigation of the role of ATXN1 in oligodendroglia and neurodegenerative diseases | NIH | National Institute on Aging | 2022 to 2025 | $2,847,875 | March 1, 2022 | December 31, 2026 | LIM, JANGHOO | reporter.nih.gov |
| Functional mapping of noncoding regulatory variants in human neuronal subtypes3. | NIH | National Institute of Mental Health | 2022 to 2025 | $2,846,517 | March 18, 2022 | January 31, 2027 | YANG, NAN | reporter.nih.gov |
| Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers | NIH | National Cancer Institute | 2021 to 2025 | $2,839,105 | April 1, 2021 | March 31, 2027 | VINCI, CHRISTINE | reporter.nih.gov |
| Decoding LRH-1 Activity in Gut Regeneration and Differentiation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,837,160 | June 14, 2021 | April 30, 2026 | BAYRER, JAMES | reporter.nih.gov |
| DEFINING MECHANISMS OF PROGENITOR BALANCE AND NEURONAL CONNECTIVITY | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,836,728 | May 1, 2020 | April 30, 2028 | ANTON, EVA S | reporter.nih.gov |
| Dissecting the thermogenic adipose niche | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,835,733 | September 1, 2022 | August 31, 2026 | TSENG, YU-HUA | reporter.nih.gov |
| Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,833,713 | June 1, 2014 | February 28, 2027 | WEINBERGER, LEOR S | reporter.nih.gov |
| Expression, Regulation and Function of the SULT1C Carcinogen-Activating Enzymes | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,833,481 | January 8, 2014 | December 31, 2026 | RUNGE-MORRIS, MELISSA A | reporter.nih.gov |
| Regulation of protein multi-functionality by 3 UTRs | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,832,000 | February 14, 2022 | December 31, 2026 | MAYR, CHRISTINE | reporter.nih.gov |
| Manipulating Neural Oscillations with Non-Invasive Sensory Stimulation for Alzheimer's Disease Intervention | NIH | National Institute on Aging | 2022 to 2025 | $2,827,960 | April 1, 2022 | January 31, 2026 | TSAI, LI-HUEI | reporter.nih.gov |
| Role of VZV Latency Transcript (VLT) and ORF63 in latency and reactivation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,825,270 | November 17, 2020 | October 31, 2026 | KINCHINGTON, PAUL R. | reporter.nih.gov |
| Translational Control of Cardiac Excitability | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,825,151 | July 15, 2016 | June 30, 2026 | ROBERTSON, GAIL A | reporter.nih.gov |
| Investigating human cis-regulatory evolution with hybrid iPS cells | NIH | National Human Genome Research Institute | 2022 to 2025 | $2,824,455 | May 25, 2022 | March 31, 2026 | FRASER, HUNTER B | reporter.nih.gov |
| Developing gene therapy strategies to treat alpha thalassemia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,821,947 | January 1, 2022 | December 31, 2025 | MACKENZIE, TIPPI | reporter.nih.gov |
| Cell-Type Specific Mechanisms of HIV Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,817,007 | December 6, 2021 | November 30, 2025 | CHI, NEIL C | reporter.nih.gov |
| Production of Cultured Red Blood Cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,816,822 | September 15, 2015 | March 31, 2029 | BOUHASSIRA, ERIC E. | reporter.nih.gov |
| Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,816,253 | July 1, 2016 | November 30, 2026 | ZHANG, JIANYI | reporter.nih.gov |
| Exploiting accelerated aging associated with Low Earth Orbit (LEO) environment to gain insights into pathogenesis and treatment of progressive neurological disorders | NIH | National Institute on Aging | 2025 | $2,815,841 | September 1, 2025 | August 31, 2028 | SETHU, PALANIAPPAN | reporter.nih.gov |
| Multimarker surface signatures of human islet derived extracellular vesicles | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,815,725 | September 22, 2022 | May 31, 2027 | ROUTENBERG, DAVID AARON | reporter.nih.gov |
| Analysis of protein interactions in neurodegenerative disease | NIH | National Institute on Aging | 2022 to 2025 | $2,811,410 | May 1, 2022 | April 30, 2027 | YATES III, JOHN R | reporter.nih.gov |
| The role of the intestinal microbiome in cancer immunotherapy | NIH | National Cancer Institute | 2023 to 2025 | $2,811,009 | August 1, 2023 | July 31, 2030 | VAN DEN BRINK, MARCEL R M | reporter.nih.gov |
| Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,809,429 | July 10, 2019 | June 30, 2029 | BURDETTE, JOANNA E | reporter.nih.gov |
| Prdm3/16 Regulate Chromatin Accessibility to Determine Alveolar Maturation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,805,992 | July 1, 2022 | June 30, 2027 | WHITSETT, JEFFREY A | reporter.nih.gov |
| Chromatin Dynamics During Epithelial Commitment | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,805,406 | September 1, 2024 | June 30, 2029 | ORO, ANTHONY E | reporter.nih.gov |
| Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation | NIH | National Cancer Institute | 2022 to 2025 | $2,804,127 | July 22, 2022 | June 30, 2027 | VALDIMARSDOTTIR, HEIDDIS | reporter.nih.gov |
| Biomaterials Strategies to Promote Functional Recovery After Ischemic Stroke | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,801,281 | March 1, 2020 | June 30, 2030 | SEGURA, TATIANA | reporter.nih.gov |
| Cellular and molecular analysis of B lymphocyte development and selection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,800,489 | June 15, 2014 | April 30, 2030 | PEREIRA, JOAO | reporter.nih.gov |
| Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs) | NIH | National Institute of Mental Health | 2023 to 2025 | $2,798,182 | September 1, 2023 | August 31, 2026 | PRICE, JEFFREY H. | reporter.nih.gov |
| A premalignant chronology of cell-state variability in basal-like breast cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,790,901 | January 1, 2022 | December 31, 2026 | JANES, KEVIN A | reporter.nih.gov |
| Regulation of arterial phenotype by perivascular adipose tissue in cardiometabolic disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,788,828 | July 1, 2018 | June 30, 2027 | LIAW, LUCY | reporter.nih.gov |
| Molecular Basis of cDC1 Development | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,787,883 | June 17, 2022 | May 31, 2027 | MURPHY, KENNETH M | reporter.nih.gov |
| Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,784,762 | December 20, 2021 | November 30, 2026 | KARBOWNICZEK, MAGDALENA | reporter.nih.gov |
| Targeting vascular dysfunction to promote lung repair and fibrosis resolution | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,782,716 | March 5, 2022 | February 28, 2027 | LIGRESTI, GIOVANNI | reporter.nih.gov |
| Understanding Hirschsprung disease using hPSC-derived models of the enteric nervous system | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,781,801 | September 15, 2025 | September 14, 2029 | FATTAHI, FARANAK | reporter.nih.gov |
| Vascularized Islet transplantation NICHE with local immunosuppression for the treatment of type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,778,087 | July 1, 2022 | April 30, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Defining the role of MafA in islet beta cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,772,028 | July 29, 2011 | May 31, 2027 | STEIN, ROLAND W | reporter.nih.gov |
| Developmental Exposures, Stem Cell Reprogramming, and Breast Cancer Disparities | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,767,677 | January 1, 2018 | October 31, 2027 | COLACINO, JUSTIN ADAM | reporter.nih.gov |
| Exploring the role of ATP1A3 mutations in sudden unexplained death in epilepsy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,764,922 | August 22, 2022 | June 30, 2027 | LANDSTROM, ANDREW P. | reporter.nih.gov |
| Mechanisms and Impact of Pregnancy-Induced Adaptations in Pelvic Floor Muscles | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,761,892 | August 1, 2017 | June 30, 2026 | ALPERIN, MARIANNA | reporter.nih.gov |
| TMPRSS2 as a potential target for treatments of COVID-19 and respiratory infectious viruses in lung | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,759,863 | September 1, 2022 | August 31, 2026 | CHEN, YA-WEN | reporter.nih.gov |
| Base-Edited Hematopoietic Stem and Progenitor Cells To Enable Safe Use Of Highly Potent CD33-Targeted Radioimmunotherapy | NIH | National Cancer Institute | 2022 to 2025 | $2,758,516 | July 1, 2022 | June 30, 2027 | WALTER, ROLAND BRUNO | reporter.nih.gov |
| Computational and Experimental Modeling of Cardiomyocyte Proliferation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,757,722 | January 1, 2022 | December 31, 2026 | SAUCERMAN, JEFFREY J. | reporter.nih.gov |
| Identification, Quantification, and Functional Characterization of Transporters in Human Placenta, Developing Gut and Fetal Brain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,755,586 | August 11, 2023 | June 30, 2028 | WANG, JOANNE | reporter.nih.gov |
| Functional Biointegration of Bioengineered Salivary Tissues in Irradiated Animal Models | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,754,807 | September 19, 2022 | June 30, 2027 | FARACH-CARSON, MARY C | reporter.nih.gov |
| Image-guided combination therapies for radiotherapy-induced neurocognitive impairment in pediatric brain tumor survivors | NIH | National Cancer Institute | 2021 to 2025 | $2,750,972 | July 12, 2021 | June 30, 2027 | NGEN, ETHEL JOSO | reporter.nih.gov |
| In vivo HSC gene therapy using a multi-modular HDAd vector for HIV cure | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,743,808 | January 10, 2023 | December 31, 2027 | LIEBER, ANDRE MICHAEL | reporter.nih.gov |
| Robust mapping of chromatin loops from sparse or single cell Hi-C data with DeepLoop | NIH | National Human Genome Research Institute | 2021 to 2025 | $2,742,397 | August 3, 2017 | May 31, 2027 | JIN, FULAI | reporter.nih.gov |
| Cadherin-Dependent Regulation of Satellite Cell Function | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,741,976 | July 15, 2016 | June 30, 2027 | KRAUSS, ROBERT S. | reporter.nih.gov |
| Benzodiazepine mediated mechanisms of transcriptional semi-quiescence in discrete myeloid populations | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,741,871 | September 15, 2022 | June 30, 2027 | GASKILL, PETER JESSE | reporter.nih.gov |
| Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors | NIH | National Cancer Institute | 2023 to 2025 | $2,739,146 | August 1, 2023 | July 31, 2030 | MILLER, JEFFREY S. | reporter.nih.gov |
| Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,737,027 | May 1, 2012 | March 31, 2027 | WU, JOSEPH C. | reporter.nih.gov |
| Dysregulation of the Core Binding Factor Complex Inhibits Differentiation and Drives Group 4 Medulloblastoma | NIH | National Cancer Institute | 2022 to 2025 | $2,726,662 | April 4, 2011 | August 31, 2027 | WECHSLER-REYA, ROBERT J. | reporter.nih.gov |
| Charting the differentiation topology of SF3B1 mutated clonal hematopoiesis (CH) and myelodysplastic syndromes (MDS) via a multi-omics single-cell toolkit | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,726,409 | February 15, 2022 | January 31, 2026 | LANDAU, DAN | reporter.nih.gov |
| Three-model platform for understanding DMD epigenetic mechanisms and advancing small molecule therapies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,725,938 | February 4, 2021 | December 31, 2026 | MAVES, LISA | reporter.nih.gov |
| Functional Characterization of ABCA3 Genomic Variants | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,725,575 | February 15, 2020 | June 30, 2030 | WAMBACH, JENNIFER | reporter.nih.gov |
| In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,720,700 | August 1, 2017 | April 30, 2027 | TRUSKEY, GEORGE A | reporter.nih.gov |
| Mechanism of Matrix Gla Protein (MGP); Adipose Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,719,728 | April 24, 2006 | June 30, 2027 | BOSTROM, KRISTINA I | reporter.nih.gov |
| Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,717,504 | February 1, 2021 | December 31, 2026 | SMITH, LACHLAN JAMES | reporter.nih.gov |
| Innovative therapeutic approaches to address excitotoxic CNS/neuronal damage in opioid-neuroHIV comorbidity | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,714,944 | August 15, 2022 | May 31, 2027 | HAUSER, KURT F | reporter.nih.gov |
| Modeling ASD-linked genetic mutations in 3D human brain organoids | NIH | National Institute of Mental Health | 2021 to 2025 | $2,714,855 | February 1, 2018 | June 30, 2029 | ARLOTTA, PAOLA | reporter.nih.gov |
| Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,714,234 | August 12, 2022 | July 31, 2027 | PONNUSAMY, MOORTHY P. | reporter.nih.gov |
| Development of the resident macrophage lineage in mouse and human | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,710,279 | February 8, 2017 | December 31, 2027 | GEISSMANN, FREDERIC | reporter.nih.gov |
| Metabolic and Hormonal Mechanisms of VCID | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,707,906 | April 15, 2019 | August 31, 2029 | ZULOAGA, KRISTEN LEANNE | reporter.nih.gov |
| Regulation of T cell exhaustion via 3D chromatin architecture | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,704,065 | March 15, 2015 | April 30, 2030 | XUE, HAI-HUI | reporter.nih.gov |
| Mitochondrial Regulation of Hematopoietic Stem Cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,703,143 | January 17, 2017 | December 31, 2025 | SNOECK, HANS-WILLEM E | reporter.nih.gov |
| The impact of inherited and modifiable risk factors on clonal hematopoiesis and age-related disease | NIH | National Institute on Aging | 2024 to 2025 | $2,701,324 | September 1, 2024 | June 30, 2029 | BOLTON, KELLY LEIGH | reporter.nih.gov |
| New roles of endothelial regrowth in ischemic tissue recovery and regeneration | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,697,119 | April 1, 2022 | March 31, 2027 | KUME, TSUTOMU | reporter.nih.gov |
| Regulation of DNA methylation by TETs and QSER1 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,694,857 | September 22, 2022 | August 31, 2027 | EVANS, TODD R | reporter.nih.gov |
| Emergency Myelopoiesis in the Pathogenesis of Myeloid Malignancies | NIH | National Cancer Institute | 2021 to 2025 | $2,690,224 | August 1, 2021 | July 31, 2027 | PASSEGUE, EMMANUELLE | reporter.nih.gov |
| Understanding the impact of Clusterin on the oligodendrocyte lineage in AD | NIH | National Institute on Aging | 2022 to 2025 | $2,688,657 | September 15, 2022 | August 31, 2027 | GAULTIER, ALBAN P | reporter.nih.gov |
| Clinical Significance of MHC Haplotypes in HCT | NIH | National Cancer Institute | 2021 to 2025 | $2,687,420 | March 1, 2003 | August 31, 2028 | PETERSDORF, EFFIE W | reporter.nih.gov |
| A Phase II Controlled Trial of Allogeneic Mesenchymal Stromal Cells for the Treatment of Refractory Lupus (MiSLE) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,684,733 | August 1, 2024 | May 31, 2027 | GILKESON, GARY S | reporter.nih.gov |
| Establishment of a Human Microphysiological System to Elucidate Cellular Mechanisms Underlying Vulnerability to AD | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $2,683,965 | May 1, 2025 | April 30, 2028 | YOUNG-PEARSE, TRACY L | reporter.nih.gov |
| Kidney Injury Molecule-1 in Epithelial Repair | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,678,187 | June 1, 2005 | June 30, 2027 | BONVENTRE, JOSEPH VINCENT | reporter.nih.gov |
| Implementation of an interventional, risk-adapted clinical trial for children with newly diagnosed juvenile myelomonocytic leukemia. | NIH | National Cancer Institute | 2022 to 2025 | $2,677,641 | August 1, 2022 | July 31, 2027 | STIEGLITZ, ELLIOT | reporter.nih.gov |
| Mechanisms of neuromuscular degeneration in SBMA | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,675,706 | September 1, 2021 | May 31, 2027 | LIEBERMAN, ANDREW P | reporter.nih.gov |
| Cardiomyocyte Non-autonomous Factors and Cardiac Regeneration in Large Mammals | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,675,195 | August 9, 2022 | June 30, 2027 | ZHU, WUQIANG | reporter.nih.gov |
| Pathomechanisms of SCN3A-related neurodevelopmental disorder | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,674,943 | December 1, 2020 | November 30, 2026 | GOLDBERG, ETHAN M | reporter.nih.gov |
| Intraventricular Hemorrhage Disrupts the Blood Brain Barrier in Premature Infants | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,672,389 | March 1, 2021 | February 28, 2026 | BALLABH, PRAVEEN | reporter.nih.gov |
| NSR-GENE (Neonatal Seizure Registry, GEnetics of post-Neonatal Epilepsy) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,671,951 | March 1, 2022 | February 28, 2027 | GLASS, HANNAH CRANLEY | reporter.nih.gov |
| Hematopoietic and Immune Development in the Human Chorion | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,664,107 | April 11, 2022 | March 31, 2027 | MUENCH, MARCUS O | reporter.nih.gov |
| The Molecular Regulatory Mechanism of Tooth Root Development | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,659,844 | July 19, 2012 | April 30, 2029 | CHAI, YANG | reporter.nih.gov |
| Mechanisms and therapeutic implications of human clonal hematopoiesis (CH) mutations | NIH | National Cancer Institute | 2022 to 2025 | $2,657,718 | June 15, 2022 | May 31, 2027 | PAPAPETROU, EIRINI | reporter.nih.gov |
| Autoimmune Stem-like CD8 T cells in Type 1 Diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,657,421 | June 8, 2023 | May 31, 2028 | SCHIETINGER, ANDREA | reporter.nih.gov |
| Studies of the fate of the osteoclast | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,655,069 | June 1, 1995 | December 31, 2026 | BOYCE, BRENDAN F | reporter.nih.gov |
| Transposable elements in the keratinocyte genome and their regulation during skin development and epidermal differentiation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,651,127 | March 16, 2021 | January 31, 2027 | BOTCHKAREV, VLADIMIR A | reporter.nih.gov |
| Alveolar Epithelial Cell Dysfunction in Pulmonary Fibrosis: Leveraging SFTPC Mutations for Discovery of Molecular and Cellular Targets | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,642,855 | July 15, 2019 | June 30, 2028 | BEERS, MICHAEL FRANCIS | reporter.nih.gov |
| Mechanisms of Hedgehog signaling in glioblastoma | NIH | National Cancer Institute | 2021 to 2025 | $2,642,438 | July 1, 2021 | April 30, 2026 | RALEIGH, DAVID R | reporter.nih.gov |
| Regulation of macrophage metabolism in aged muscle during recovery | NIH | National Institute on Aging | 2022 to 2025 | $2,642,202 | May 15, 2022 | April 30, 2027 | DRUMMOND, MICAH J | reporter.nih.gov |
| Modeling human trophoblast-NK cell interactions in term and preterm birth | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,640,730 | April 1, 2021 | January 31, 2027 | PARAST, MANA M | reporter.nih.gov |
| Engineering High-Fidelity Human Cochlear Organoids | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $2,639,492 | July 1, 2022 | June 30, 2027 | HASHINO, ERI | reporter.nih.gov |
| Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,636,174 | July 13, 2022 | April 30, 2027 | PARK, DONGSU | reporter.nih.gov |
| Stress and Human Stem/Progenitor Cells: Biobehavioral Mechanisms | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,635,227 | August 15, 2022 | June 30, 2027 | WADHWA, PATHIK D | reporter.nih.gov |
| Novel targeted therapy for treating Ovarian Cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,633,406 | August 1, 2022 | July 31, 2027 | VADLAMUDI, RATNA K | reporter.nih.gov |
| Role of progenitor exhausted CD8 T cells and the progenitor niche in anti-PD1 efficacy | NIH | National Cancer Institute | 2022 to 2025 | $2,633,070 | September 1, 2022 | August 31, 2027 | HUANG, ALEXANDER | reporter.nih.gov |
| A Bioengineering Approach to Develop a Laminar 3D Cerebellar Neuronal Circuit for Modeling Human Cerebellum | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,630,611 | April 15, 2022 | March 31, 2027 | MILLEN, KATHLEEN JOYCE | reporter.nih.gov |
| Identification and characterization of mCpH binding proteins in neurons | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,629,388 | August 5, 2022 | July 31, 2027 | ZHU, HENG | reporter.nih.gov |
| Disease Mechanisms of Pontocerebellar Hypoplasia Type 10 | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,628,742 | July 1, 2021 | March 17, 2026 | SCHAFFER, ASHLEIGH E | reporter.nih.gov |
| Triglycerides as a Predictor of Newborn Subcutaneous and Liver Fat: Contributors to Fetal Fat Accretion in Obese Pregnancies | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,620,225 | May 7, 2021 | March 31, 2027 | BARBOUR, LINDA ANNE | reporter.nih.gov |
| Biomechanical Forces and the Enteric Nervous System: Advancing the Development and Function of Tissue-Engineered Intestine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,618,975 | September 8, 2025 | September 7, 2029 | SPEER, ALLISON LEIGH | reporter.nih.gov |
| Mechanisms of Disease and Treatment in Novel Metabolic Developmental Brain Disorders | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,618,366 | December 1, 2021 | November 30, 2026 | MORROW, ERIC M | reporter.nih.gov |
| Mechanisms of telomere-induced disease: Role of intestinal malabsorption, barrier dysfunction and dsybiosis. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,617,623 | June 1, 2022 | March 31, 2027 | SAHIN, ERGUN | reporter.nih.gov |
| Bioresorbable Zinc Staples for Anastomoses in the Digestive Tract | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,616,912 | February 3, 2022 | January 31, 2027 | ZHU, DONGHUI | reporter.nih.gov |
| Characterizing and Understanding Variation in Gene Regulatory Mechanisms Within and Between Species | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,610,282 | June 1, 2019 | May 31, 2029 | GILAD, YOAV | reporter.nih.gov |
| Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,608,897 | August 15, 2022 | May 31, 2027 | MACIEJEWSKI, JAROSLAW P. | reporter.nih.gov |
| Transcriptional networks establishing the precise gene expression states that define neurosensory cell identity in the inner ear | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,603,881 | February 1, 2016 | June 30, 2027 | XU, PIN-XIAN | reporter.nih.gov |
| Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy | NIH | National Cancer Institute | 2022 to 2025 | $2,603,837 | August 1, 2022 | June 30, 2027 | LI, CHUN | reporter.nih.gov |
| Cell fate choices by Tbx1 in forming the mammalian heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,603,457 | August 20, 2020 | April 30, 2029 | MORROW, BERNICE E | reporter.nih.gov |
| Marfan Aortic Embryologic Origin Influences Aneurysm Formation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,603,051 | April 1, 2016 | March 31, 2027 | FISCHBEIN, MICHAEL PETER | reporter.nih.gov |
| Genetic Regulatory Network in Craniofacial Development | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,599,984 | March 12, 2025 | January 31, 2030 | HSU, WEI | reporter.nih.gov |
| Defining Pathogenic Mechanisms and Therapeutic Opportunities for Langerhans Cell Histiocytosis | NIH | National Cancer Institute | 2022 to 2025 | $2,594,306 | January 14, 2011 | December 31, 2026 | MERAD, MIRIAM | reporter.nih.gov |
| Suturable bioprinted vascularized muscle constructs for treatment of skeletal muscle loss | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,591,324 | March 1, 2021 | February 28, 2027 | SHIN, SU RYON | reporter.nih.gov |
| An Interneuron-based Cell Therapy for Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,589,602 | September 1, 2010 | March 31, 2027 | BARABAN, SCOTT C | reporter.nih.gov |
| Development of a stem-cell derived thymic cell therapy to treat patients with athymia | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,586,728 | April 15, 2022 | January 31, 2027 | LIM, BING | reporter.nih.gov |
| Heterogeneity of Satellite Cell Populations Play a Role in Improvements in PAD after Exercise Therapy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,586,669 | February 15, 2022 | January 31, 2027 | HANSEN, LAURA MARIE | reporter.nih.gov |
| Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal Hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,584,743 | April 1, 2022 | August 31, 2026 | LIBBY, PETER | reporter.nih.gov |
| Single Cell Tracking of 3D Epigenetic Landscape Evolution During Embryonic Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,584,586 | March 1, 2022 | February 28, 2027 | ZHONG, SHENG | reporter.nih.gov |
| Small Molecule Drug Discovery for CLN3 and CLN6 Disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,584,107 | September 20, 2021 | June 30, 2027 | TRIPPIER, PAUL | reporter.nih.gov |
| Microribbon scaffold-mediated Immunomodulation for Cranial Bone Repair | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,582,020 | January 1, 2015 | May 31, 2027 | YANG, FAN | reporter.nih.gov |
| Cell lineage and transcriptional analysis of the vertebrate neural plate border | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,580,495 | February 1, 2018 | January 31, 2028 | BRONNER, MARIANNE | reporter.nih.gov |
| ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism | NIH | National Cancer Institute | 2022 to 2025 | $2,576,142 | January 1, 2022 | April 30, 2027 | SHUREIQI, IMAD | reporter.nih.gov |
| Assembly and characterization of human cortico-striatal neural networks | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,570,801 | August 1, 2021 | May 31, 2027 | SHCHEGLOVITOV, OLEKSANDR | reporter.nih.gov |
| VZV vaccine attenuation and the DNA damage response | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,569,364 | July 1, 2022 | June 30, 2027 | KINCHINGTON, PAUL R. | reporter.nih.gov |
| Site-specific Integration of Large (10-100 kb) DNA Constructs into the Mouse Genome and Human Induced Pluripotent Stem Cells Using the Cas9-Bxb1 Integrase Toolbox | NIH | National Cancer Institute | 2022 to 2025 | $2,568,438 | July 1, 2022 | June 30, 2027 | HOSUR, VISHNU | reporter.nih.gov |
| Modeling Normal and Abnormal Trophoblasts | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,565,353 | September 25, 2018 | March 31, 2028 | SCHULZ, LAURA CLAMON | reporter.nih.gov |
| Regulation of catagen regression and progenitor pruning by the dermal sheath | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,565,274 | July 1, 2021 | June 30, 2026 | RENDL, MICHAEL | reporter.nih.gov |
| Impact of mutational order on molecular mechanisms of oncogenesis | NIH | National Cancer Institute | 2022 to 2025 | $2,563,938 | May 10, 2022 | February 28, 2027 | PAPAPETROU, EIRINI | reporter.nih.gov |
| Bioinspired Mechanically Stiff Hydrogels for Osteochondral Tissue Regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,563,338 | July 25, 2016 | March 31, 2027 | BRYANT, STEPHANIE J | reporter.nih.gov |
| Zfp423 Mechanisms in Joubert Syndrome and Related Disorders | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,562,908 | February 1, 2017 | May 31, 2027 | HAMILTON, BRUCE A | reporter.nih.gov |
| Mechanisms for Regenerative Healing in Intervertebral Discs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,560,545 | January 15, 2022 | December 31, 2026 | IATRIDIS, JAMES C. | reporter.nih.gov |
| Defining the mechanisms regulating adipose tissue metabolic memory and its role in rebound weight gain. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,559,138 | September 7, 2025 | August 31, 2029 | MERRICK, DAVID MICHAEL | reporter.nih.gov |
| Multimodal Optical Imaging on the Effect of Maternal Polysubstance Exposure on Fetal Brain Microvessel Function | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,556,302 | January 1, 2016 | July 31, 2027 | LARIN, KIRILL V | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Stanford University | Stanford, CA | 127 | $180.7 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 99 | $157.2 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 94 | $154.2 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 88 | $150.2 million | 0 | $0 |
| University of Washington | Seattle, WA | 51 | $138.7 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 85 | $136.6 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 39 | $123.8 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 96 | $114.8 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 42 | $106.5 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 90 | $104.8 million | 0 | $0 |
| Duke University | Durham, NC | 65 | $100.6 million | 0 | $0 |
| Washington University | Saint Louis, MO | 69 | $97.3 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 58 | $94.7 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 61 | $88 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 56 | $86.9 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 17 | $85.3 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 68 | $83.1 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 55 | $82.6 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 64 | $80.8 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 52 | $70 million | 0 | $0 |
| Yale University | New Haven, CT | 51 | $68.3 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 46 | $66.8 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 44 | $66.4 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 44 | $64.6 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 45 | $64.4 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 41 | $64.4 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 50 | $64.3 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 48 | $63 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 42 | $62.6 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 50 | $61.7 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 33 | $60.5 million | 0 | $0 |
| Emory University | Atlanta, GA | 47 | $60.1 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 41 | $52.4 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 13 | $51.1 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 29 | $50.7 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 31 | $48.8 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 27 | $48.7 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 27 | $47.9 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 20 | $47.2 million | 0 | $0 |
| University of Rochester | Rochester, NY | 34 | $46.9 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 32 | $46.4 million | 0 | $0 |
| University of Florida | Gainesville, FL | 28 | $44.1 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 20 | $42.9 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 32 | $42.7 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 34 | $41.6 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 29 | $40.7 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 15 | $37.5 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 24 | $37.2 million | 0 | $0 |
| University of California at Davis | Davis, CA | 29 | $35.8 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 23 | $33.5 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 20 | $33.4 million | 0 | $0 |
| University of Chicago | Chicago, IL | 29 | $33 million | 0 | $0 |
| Ohio State University | Columbus, OH | 22 | $32.3 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 21 | $31 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 22 | $30.4 million | 0 | $0 |
| Rockefeller University | New York, NY | 14 | $29.2 million | 0 | $0 |
| Columbia University | New York, NY | 14 | $27.7 million | 0 | $0 |
| National Collegiate Inventors and Innovators Alliance | Hadley, MA | 1 | $27.5 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 22 | $27.2 million | 0 | $0 |
| ST. Jude Children's Research Hospital | Memphis, TN | 20 | $26.7 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 25 | $26.5 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 19 | $26 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 21 | $25.4 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 14 | $25.3 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 19 | $25.3 million | 0 | $0 |
| The Emmes Company, LLC | Rockville, MD | 1 | $25.3 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 18 | $24.8 million | 0 | $0 |
| Buck Institute for Research on Aging | Novato, CA | 6 | $24 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 19 | $23.7 million | 0 | $0 |
| Jackson Laboratory | Bar Harbor, ME | 10 | $23.7 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 17 | $23.3 million | 0 | $0 |
| J. David Gladstone Institutes | San Francisco, CA | 13 | $23.1 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 12 | $22.5 million | 0 | $0 |
| University of California-Santa Cruz | Santa Cruz, CA | 8 | $22.5 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 14 | $22.2 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 13 | $20.4 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 17 | $19.6 million | 0 | $0 |
| Harvard University | Cambridge, MA | 17 | $19.2 million | 0 | $0 |
| University of Colorado at Boulder | Boulder, CO | 12 | $19.1 million | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 18 | $19 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 13 | $18.8 million | 0 | $0 |
| Brown University | Providence, RI | 10 | $18.6 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 19 | $18.4 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 18 | $18.4 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 8 | $18.2 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 13 | $18 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 22 | $17.1 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 17 | $17.1 million | 0 | $0 |
| Methodist Hospital Research Institute | Houston, TX | 8 | $16.2 million | 0 | $0 |
| Mayo Clinic Jacksonville | Jacksonville, FL | 11 | $15.7 million | 0 | $0 |
| Coriell Institute for Medical Research | Camden, NJ | 4 | $14.7 million | 0 | $0 |
| Cornell University | Ithaca, NY | 14 | $14.7 million | 0 | $0 |
| Rutgers University New Brunswick | New Brunswick, NJ | 10 | $14.4 million | 0 | $0 |
| Texas A&m University Health Science CTR | College Station, TX | 10 | $13.6 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 16 | $13.5 million | 0 | $0 |
| Purdue University | West Lafayette, IN | 10 | $13.4 million | 0 | $0 |
| University of Texas at San Antonio | San Antonio, TX | 4 | $13.4 million | 0 | $0 |
| Cold Spring Harbor Laboratory | Cold Spring Harbor, NY | 9 | $12.6 million | 0 | $0 |
| Sanford Burnham Prebys Medical Discovery Institute | La Jolla, CA | 9 | $12.6 million | 0 | $0 |
| H. Lee Moffitt Cancer CTR & Res Inst | Tampa, FL | 10 | $12.2 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 3,819 | $2,015,156,961 | 0 | $0 |
| 2024 | 2,721 | $1,406,046,006 | 0 | $0 |
| 2023 | 1,877 | $1,064,316,491 | 0 | $0 |
| 2022 | 1,276 | $769,268,576 | 0 | $0 |
| 2021 | 752 | $453,614,485 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.